Till sidinnehåll
Kunskapsbank för cancervården Till cancercentrum.se

Referenser

Abacioglu, U., Uzel, O., Sengoz, M., Turkan, S., & Ober, A. (2002). Medulloblastoma in adults: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys, 54(3), 855-860. doi:10.1016/s0360-3016(02)02986-3

Adra, N., Abonour, R., Althouse, S. K., Albany, C., Hanna, N. H., & Einhorn, L. H. (2017). High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience. J Clin Oncol, 35(10), 1096-1102. doi:10.1200/jco.2016.69.5395

Ajithkumar, T., Horan, G., Padovani, L., Thorp, N., Timmermann, B., Alapetite, C., . . . Janssens, G. O. (2018). SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy. Radiother Oncol, 128(2), 192-197. doi:10.1016/j.radonc.2018.04.016

Akyurek, S., Chang, E. L., Yu, T. K., Little, D., Allen, P. K., McCutcheon, I., . . . Woo, S. Y. (2006). Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center. J Neurooncol, 80(2), 177-183. doi:10.1007/s11060-006-9169-2

Alapetite, C., Brisse, H., Patte, C., Raquin, M. A., Gaboriaud, G., Carrie, C., . . . Bouffet, E. (2010). Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Neuro Oncol, 12(12), 1318-1325. doi:10.1093/neuonc/noq093

Alattar, A. A., Brandel, M. G., Hirshman, B. R., Dong, X., Carroll, K. T., Ali, M. A., . . . Chen, C. C. (2017). Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis. J Neurosurg, 1-8. doi:10.3171/2016.11.JNS161974

Albert, F. K., Forsting, M., Sartor, K., Adams, H. P., & Kunze, S. (1994). Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery, 34(1), 45-60; discussion 60-41.

Albert, N. L., Weller, M., Suchorska, B., Galldiks, N., Soffietti, R., Kim, M. M., . . . Tonn, J. C. (2016). Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol, 18(9), 1199-1208. doi:10.1093/neuonc/now058

Albrecht, T. A., & Taylor, A. G. (2012). Physical activity in patients with advanced-stage cancer: a systematic review of the literature. Clin J Oncol Nurs, 16(3), 293-300. doi:10.1188/12.Cjon.293-300

Allen, J. C., Kim, J. H., & Packer, R. J. (1987). Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system. J Neurosurg, 67(1), 65-70. doi:10.3171/jns.1987.67.1.0065

Andersen, A. P. (1978). Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol Oncol Radiat Phys Biol, 17(6), 475-484.

Anic, G. M., Madden, M. H., Nabors, L. B., Olson, J. J., LaRocca, R. V., Thompson, Z. J., . . . Egan, K. M. (2014). Reproductive factors and risk of primary brain tumors in women. J Neurooncol, 118(2), 297-304. doi:10.1007/s11060-014-1427-0

Aoyama, H., Shirato, H., Ikeda, J., Fujieda, K., Miyasaka, K., & Sawamura, Y. (2002). Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors. J Clin Oncol, 20(3), 857-865. doi:10.1200/jco.2002.20.3.857

Aoyama, H., Tago, M., Kato, N., Toyoda, T., Kenjyo, M., Hirota, S., . . . Shirato, H. (2007). Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys, 68(5), 1388-1395. doi:10.1016/j.ijrobp.2007.03.048

Armstrong, T. S., Cron, S. G., Bolanos, E. V., Gilbert, M. R., & Kang, D. H. (2010). Risk factors for fatigue severity in primary brain tumor patients. Cancer, 116(11), 2707-2715. doi:10.1002/cncr.25018

Asher, A., Fu, J. B., Bailey, C., & Hughes, J. K. (2016). Fatigue among patients with brain tumors. CNS Oncol, 5(2), 91-100. doi:10.2217/cns-2015-0008

Asklund, T., Henriksson, R., Axelsson, J., Bergstrom, A., Kasper, M., Ogren, M., . . . Riklund, K. A. (2013). Early and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma. Acta Oncol, 52(4), 862-866. doi:10.3109/0284186x.2012.724537

Atalar, B., Ozsahin, M., Call, J., Napieralska, A., Kamer, S., Villa, S., . . . Sio, T. T. (2018). Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience. Radiother Oncol, 127(1), 96-102. doi:10.1016/j.radonc.2017.12.028

Back, M., Back, E., Kastelan, M., & Wheeler, H. (2014). Cognitive Deficits in Primary Brain Tumours: A Framework for Management and Rehabilitation. Journal of Cancer Therapy, 05, 74-81. doi:10.4236/jct.2014.51010

Back, M. F., Ang, E. L., Ng, W. H., See, S. J., Lim, C. C., Tay, L. L., & Yeo, T. T. (2007). Improvements in quality of care resulting from a formal multidisciplinary tumour clinic in the management of high-grade glioma. Ann Acad Med Singapore, 36(5), 347-351.

Balmaceda, C., Heller, G., Rosenblum, M., Diez, B., Villablanca, J. G., Kellie, S., . . . Finlay, J. L. (1996). Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol, 14(11), 2908-2915. doi:10.1200/jco.1996.14.11.2908

Balter-Seri, J., Mor, C., Shuper, A., Zaizov, R., & Cohen, I. J. (1997). Cure of recurrent medulloblastoma: the contribution of surgical resection at relapse. Cancer, 79(6), 1241-1247. doi:10.1002/(sici)1097-0142(19970315)79:6<1241::aid-cncr25>3.0.co;2-z

Bamberg, M., Kortmann, R. D., Calaminus, G., Becker, G., Meisner, C., Harms, D., & Gobel, U. (1999). Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol, 17(8), 2585-2592. doi:10.1200/jco.1999.17.8.2585

Baranzelli, M. C., Patte, C., Bouffet, E., Portas, M., Mechinaud-Lacroix, F., Sariban, E., . . . Kalifa, C. (1998). An attempt to treat pediatric intracranial alphaFP and betaHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases. Societe Francaise d'Oncologie Pediatrique. J Neurooncol, 37(3), 229-239.

Barker, C. A., Bishop, A. J., Chang, M., Beal, K., & Chan, T. A. (2013). Valproic acid use during radiation therapy for glioblastoma associated with improved survival. Int J Radiat Oncol Biol Phys, 86(3), 504-509. doi:10.1016/j.ijrobp.2013.02.012

Barney, C. L., Brown, A. P., Grosshans, D. R., McAleer, M. F., de Groot, J. F., Puduvalli, V., . . . Mahajan, A. (2014). Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation. Neuro Oncol, 16(2), 303-309. doi:10.1093/neuonc/not155

Bartolo, M., Zucchella, C., Pace, A., Lanzetta, G., Vecchione, C., Bartolo, M., . . . Pierelli, F. (2012). Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours. J Neurooncol, 107(3), 537-544. doi:10.1007/s11060-011-0772-5

Batchelor, T. T., Mulholland, P., Neyns, B., Nabors, L. B., Campone, M., Wick, A., . . . van den Bent, M. (2013). Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma. J Clin Oncol, 31(26), 3212-3218. doi:10.1200/JCO.2012.47.2464

Baumert, B. G., Hegi, M. E., van den Bent, M. J., von Deimling, A., Gorlia, T., Hoang-Xuan, K., . . . Stupp, R. (2016). Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncol, 17(11), 1521-1532. doi:10.1016/S1470-2045(16)30313-8

Beier, D., Proescholdt, M., Reinert, C., Pietsch, T., Jones, D. T. W., Pfister, S. M., . . . Hau, P. (2018). Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Neuro Oncol, 20(3), 400-410. doi:10.1093/neuonc/nox155

Bell, E. H., Zhang, P., Fisher, B. J., Macdonald, D. R., McElroy, J. P., Lesser, G. J., . . . Chakravarti, A. (2018). Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial. JAMA Oncol, 4(10), 1405-1409. doi:10.1001/jamaoncol.2018.1977

Bennett, S. J., Katzman, G. L., Roos, R. P., Mehta, A. S., & Ali, S. (2016). Neoplastic cauda equina syndrome: a neuroimaging-based review. Pract Neurol, 16(1), 35-41. doi:10.1136/practneurol-2015-001236

Benson, V. S., Pirie, K., Green, J., Casabonne, D., Beral, V., & Million Women Study, C. (2008). Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer, 99(1), 185-190. doi:10.1038/sj.bjc.6604445

Berendsen, S., Broekman, M., Seute, T., Snijders, T., van Es, C., de Vos, F., . . . Robe, P. (2012). Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results. Expert Opin Investig Drugs, 21(9), 1391-1415. doi:10.1517/13543784.2012.694425

Bergenheim, T., Malmstrom, A., Bolander, H., Michanek, A., Stragliotto, G., Damber, L., . . . Henriksson, R. (2007). [Registration on regional basis of patients with primary brain tumors. Regional differences disclosed]. Lakartidningen, 104(5), 332-338, 340-331.

Berntsson, S. G., Falk, A., Savitcheva, I., Godau, A., Zetterling, M., Hesselager, G., . . . Smits, A. (2013). Perfusion and diffusion MRI combined with (1)(1)C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas. J Neurooncol, 114(2), 241-249. doi:10.1007/s11060-013-1178-3

Björkdahl, A. (2015). Kognitiv rehabilitering : teoretisk grund och praktisk tillämpning. Lund: Studentlitteratur.

Bloch, O., Han, S. J., Cha, S., Sun, M. Z., Aghi, M. K., McDermott, M. W., . . . Parsa, A. T. (2012). Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg, 117(6), 1032-1038. doi:10.3171/2012.9.JNS12504

Blommengren, A., & Ohlgren, B. (2007). Neurokirurgisk vård. Lund: Studentlitteratur.

Blonski, M., Taillandier, L., Herbet, G., Maldonado, I. L., Beauchesne, P., Fabbro, M., . . . Duffau, H. (2012). Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life. J Neurooncol, 106(2), 353-366. doi:10.1007/s11060-011-0670-x

Blumenthal, D. T., Gorlia, T., Gilbert, M. R., Kim, M. M., Burt Nabors, L., Mason, W. P., . . . Stupp, R. (2017). Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG. Neuro Oncol, 19(8), 1119-1126. doi:10.1093/neuonc/nox025

Blumenthal, D. T., Parreno, M. G., Batten, J., & Chamberlain, M. C. (2008). Management of malignant gliomas during pregnancy: a case series. Cancer, 113(12), 3349-3354. doi:10.1002/cncr.23973

Bobustuc, G. C., Baker, C. H., Limaye, A., Jenkins, W. D., Pearl, G., Avgeropoulos, N. G., & Konduri, S. D. (2010). Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro Oncol, 12(9), 917-927. doi:10.1093/neuonc/noq044

Bond, K. M., Hughes, J. D., Porter, A. L., Orina, J., Fang, S., & Parney, I. F. (2018). Adult Pilocytic Astrocytoma: An Institutional Series and Systematic Literature Review for Extent of Resection and Recurrence. World Neurosurg, 110, 276-283. doi:10.1016/j.wneu.2017.11.102

Bouffet, E., & Foreman, N. (1999). Chemotherapy for intracranial ependymomas. Childs Nerv Syst, 15(10), 563-570. doi:10.1007/s003810050544

Brada, M., Hoang-Xuan, K., Rampling, R., Dietrich, P. Y., Dirix, L. Y., Macdonald, D., . . . Zaknoen, S. (2001). Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol, 12(2), 259-266.

Brada, M., Stenning, S., Gabe, R., Thompson, L. C., Levy, D., Rampling, R., . . . Lee, S. M. (2010). Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. J Clin Oncol, 28(30), 4601-4608. doi:10.1200/JCO.2009.27.1932

Brada, M., Viviers, L., Abson, C., Hines, F., Britton, J., Ashley, S., . . . Westbury, C. (2003). Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol, 14(12), 1715-1721.

Brandes, A. A., Cavallo, G., Reni, M., Tosoni, A., Nicolardi, L., Scopece, L., . . . Ermani, M. (2005). A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia. Cancer, 104(1), 143-148. doi:10.1002/cncr.21110

Brandes, A. A., Ermani, M., Amista, P., Basso, U., Vastola, F., Gardiman, M., . . . Berti, F. (2003). The treatment of adults with medulloblastoma: a prospective study. Int J Radiat Oncol Biol Phys, 57(3), 755-761. doi:10.1016/s0360-3016(03)00643-6

Brandes, A. A., Franceschi, E., Tosoni, A., Blatt, V., & Ermani, M. (2007). Long-term results of a prospective study on the treatment of medulloblastoma in adults. Cancer, 110(9), 2035-2041. doi:10.1002/cncr.23003

Brandes, A. A., Franceschi, E., Tosoni, A., Blatt, V., Pession, A., Tallini, G., . . . Ermani, M. (2008). MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol, 26(13), 2192-2197. doi:10.1200/jco.2007.14.8163

Brandner, S., & Jaunmuktane, Z. (2018). Neurological update: gliomas and other primary brain tumours in adults. J Neurol, 265(3), 717-727. doi:10.1007/s00415-017-8652-3

Brat, D. J., Aldape, K., Colman, H., Holland, E. C., Louis, D. N., Jenkins, R. B., . . . Weller, M. J. A. N. (2018). cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”. 136(5), 805-810. doi:10.1007/s00401-018-1913-0

Brodie, M. J., Mintzer, S., Pack, A. M., Gidal, B. E., Vecht, C. J., & Schmidt, D. (2013). Enzyme induction with antiepileptic drugs: cause for concern? Epilepsia, 54(1), 11-27. doi:10.1111/j.1528-1167.2012.03671.x

Brown, N. F., Carter, T., & Mulholland, P. (2017). Dabrafenib in BRAFV600-mutated anaplastic pleomorphic xanthoastrocytoma. CNS Oncol, 6(1), 5-9. doi:10.2217/cns-2016-0031

Buckner, J. C., Gesme, D., Jr., O'Fallon, J. R., Hammack, J. E., Stafford, S., Brown, P. D., . . . Jenkins, R. (2003). Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol, 21(2), 251-255.

Buckner, J. C., Peethambaram, P. P., Smithson, W. A., Groover, R. V., Schomberg, P. J., Kimmel, D. W., . . . Shaw, E. G. (1999). Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors. J Clin Oncol, 17(3), 933-940. doi:10.1200/jco.1999.17.3.933

Buckner, J. C., Shaw, E. G., Pugh, S. L., Chakravarti, A., Gilbert, M. R., Barger, G. R., . . . Curran, W. J., Jr. (2016). Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. N Engl J Med, 374(14), 1344-1355. doi:10.1056/NEJMoa1500925

Cairncross, G., Wang, M., Shaw, E., Jenkins, R., Brachman, D., Buckner, J., . . . Mehta, M. (2013). Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol, 31(3), 337-343. doi:10.1200/JCO.2012.43.2674

Calaminus, G., Andreussi, L., Garre, M. L., Kortmann, R. D., Schober, R., & Gobel, U. (1997). Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT). Klin Padiatr, 209(4), 222-227. doi:10.1055/s-2008-1043954

Calaminus, G., Bamberg, M., Harms, D., Jurgens, H., Kortmann, R. D., Sorensen, N., . . . Gobel, U. (2005). AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics, 36(2), 71-77. doi:10.1055/s-2005-837582

Calaminus, G., Kortmann, R., Worch, J., Nicholson, J. C., Alapetite, C., Garre, M. L., . . . Frappaz, D. (2013). SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol, 15(6), 788-796. doi:10.1093/neuonc/not019

Cancer i Siffror 2018. Retrieved from https://www.cancerfonden.se/cancer-i-siffror

Capelle, L., Fontaine, D., Mandonnet, E., Taillandier, L., Golmard, J. L., Bauchet, L., . . . French Reseau d'Etude des, G. (2013). Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article. J Neurosurg, 118(6), 1157-1168. doi:10.3171/2013.1.JNS121

Capper, D., Weissert, S., Balss, J., Habel, A., Meyer, J., Jager, D., . . . von Deimling, A. (2010). Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol, 20(1), 245-254. doi:10.1111/j.1750-3639.2009.00352.x

Carney, B. J., Uhlmann, E. J., Puligandla, M., Mantia, C., Weber, G. M., Neuberg, D. S., & Zwicker, J. I. (2019). Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors. J Thromb Haemost, 17(1), 72-76. doi:10.1111/jth.14336

Cefalo, G., Massimino, M., Ruggiero, A., Barone, G., Ridola, V., Spreafico, F., . . . Riccardi, R. (2014). Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial. Neuro Oncol, 16(5), 748-753. doi:10.1093/neuonc/not320

Chabner, B. A., & Longo, D. L. (2006). Cancer chemotherapy and biotherapy : principles and practice. Philadelphia, Pa.: Lippincott Williams & Wilkins.

Chamberlain, M. C. (2002). Salvage chemotherapy for recurrent spinal cord ependymona. Cancer, 95(5), 997-1002. doi:10.1002/cncr.10826

Chamberlain, M. C. (2013). Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series. J Neurooncol, 114(2), 237-240. doi:10.1007/s11060-013-1176-5

Chamberlain, M. C., & Tredway, T. L. (2011). Adult primary intradural spinal cord tumors: a review. Curr Neurol Neurosci Rep, 11(3), 320-328. doi:10.1007/s11910-011-0190-2

Chan, A. W., Tarbell, N. J., Black, P. M., Louis, D. N., Frosch, M. P., Ancukiewicz, M., . . . Loeffler, J. S. (2000). Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery, 47(3), 623-631; discussion 631-622. doi:10.1097/00006123-200009000-00018

Chan, J. L., Lee, S. W., Fraass, B. A., Normolle, D. P., Greenberg, H. S., Junck, L. R., . . . Sandler, H. M. (2002). Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol, 20(6), 1635-1642.

Chandana, S. R., Movva, S., Arora, M., & Singh, T. (2008). Primary brain tumors in adults. Am Fam Physician, 77(10), 1423-1430.

Chang, C. H., Housepian, E. M., & Herbert, C., Jr. (1969). An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology, 93(6), 1351-1359. doi:10.1148/93.6.1351

Chang, E. L., Brown, P. D., Lo, S. S., Sahgal, A., & Suh, J. H. (2018). Adult CNS Radiation Oncology Principles and Practice. Cham: Springer International Publishing :.

Chang, S. M., Parney, I. F., Huang, W., Anderson, F. A., Jr., Asher, A. L., Bernstein, M., . . . Glioma Outcomes Project, I. (2005). Patterns of care for adults with newly diagnosed malignant glioma. JAMA, 293(5), 557-564. doi:10.1001/jama.293.5.557

Charters, E., Gillett, L., & Simpson, G. K. (2015). Efficacy of electronic portable assistive devices for people with acquired brain injury: a systematic review. Neuropsychol Rehabil, 25(1), 82-121. doi:10.1080/09602011.2014.942672

Chelf, J. H., Agre, P., Axelrod, A., Cheney, L., Cole, D. D., Conrad, K., . . . Weaver, C. (2001). Cancer-related patient education: an overview of the last decade of evaluation and research. Oncol Nurs Forum, 28(7), 1139-1147.

Chinot, O. L., Wick, W., Mason, W., Henriksson, R., Saran, F., Nishikawa, R., . . . Cloughesy, T. (2014). Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med, 370(8), 709-722. doi:10.1056/NEJMoa1308345

Chow, E. J., Stratton, K. L., Leisenring, W. M., Oeffinger, K. C., Sklar, C. A., Donaldson, S. S., . . . Green, D. M. (2016). Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol, 17(5), 567-576. doi:10.1016/S1470-2045(16)00086-3

Combs, S. E., Thilmann, C., Edler, L., Debus, J., & Schulz-Ertner, D. (2005). Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol, 23(34), 8863-8869. doi:10.1200/JCO.2005.03.4157

Compston, J. (2010). Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol, 6(2), 82-88. doi:10.1038/nrrheum.2009.259

Cramp, F., & Daniel, J. (2008). Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev(2), CD006145. doi:10.1002/14651858.CD006145.pub2

Cytostatikabehandling vid cancer Vol. 1. (2001). Stockholm: SBU.

Daniels, T. B., Brown, P. D., Felten, S. J., Wu, W., Buckner, J. C., Arusell, R. M., . . . Shaw, E. G. (2011). Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys, 81(1), 218-224. doi:10.1016/j.ijrobp.2010.05.003

Daras, M., Cone, C., & Peters, K. B. (2014). Tumor progression and transformation of low-grade glial tumors associated with pregnancy. J Neurooncol, 116(1), 113-117. doi:10.1007/s11060-013-1261-9

Davies, E., & Higginson, I. J. (2003). Communication, information and support for adults with malignant cerebral glioma : a systematic literature review. Support Care Cancer, 11(1), 21-29. doi:10.1007/s00520-002-0392-x

De, B., Beal, K., De Braganca, K. C., Souweidane, M. M., Dunkel, I. J., Khakoo, Y., . . . Wolden, S. L. (2018). Long-term outcomes of adult medulloblastoma patients treated with radiotherapy. J Neurooncol, 136(1), 95-104. doi:10.1007/s11060-017-2627-1

De Bonis, P., Fiorentino, A., Anile, C., Balducci, M., Pompucci, A., Chiesa, S., . . . Mangiola, A. (2013). The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma. Clin Neurol Neurosurg, 115(7), 883-886. doi:10.1016/j.clineuro.2012.08.030

De Nijs, R. N. (2008). Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. Minerva Med, 99(1), 23-43.

DeAngelis, L. M., Delattre, J. Y., & Posner, J. B. (1989). Radiation-induced dementia in patients cured of brain metastases. Neurology, 39(6), 789-796.

Denis, F., Lethrosne, C., Pourel, N., Molinier, O., Pointreau, Y., Domont, J., . . . Letellier, C. (2017). Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients. J Natl Cancer Inst, 109(9). doi:10.1093/jnci/djx029

Deutsch, M., Green, S. B., Strike, T. A., Burger, P. C., Robertson, J. T., Selker, R. G., . . . et al. (1989). Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys, 16(6), 1389-1396.

Deutsch, M., Thomas, P. R., Krischer, J., Boyett, J. M., Albright, L., Aronin, P., . . . Vietti, T. (1996). Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group Study. Pediatr Neurosurg, 24(4), 167-176; discussion 176-167. doi:10.1159/000121042

DeWire, M., Fouladi, M., Turner, D. C., Wetmore, C., Hawkins, C., Jacobs, C., . . . Gajjar, A. (2015). An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN). J Neurooncol, 123(1), 85-91. doi:10.1007/s11060-015-1764-7

Dirven, L., Sizoo, E. M., & Taphoorn, M. J. (2015). Anaplastic gliomas: end-of-life care recommendations. CNS Oncol, 4(5), 357-365. doi:10.2217/cns.15.31

Doherty, L., & LaFrankie, D. C. (2010). Patient safety concerns for cognitively impaired patients with brain tumors. Clin J Oncol Nurs, 14(1), 101-102. doi:10.1188/10.CJON.101-102

Douw, L., Klein, M., Fagel, S. S., van den Heuvel, J., Taphoorn, M. J., Aaronson, N. K., . . . Heimans, J. J. (2009). Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol, 8(9), 810-818. doi:10.1016/S1474-4422(09)70204-2

Drudge-Coates, L., & Rajbabu, K. (2008). Diagnosis and management of malignant spinal cord compression: part 1. Int J Palliat Nurs, 14(3), 110-116. doi:10.12968/ijpn.2008.14.3.28890

Ducassou, A., Padovani, L., Chaltiel, L., Bolle, S., Habrand, J. L., Claude, L., . . . Laprie, A. (2018). Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Societe Francaise de lutte contre les Cancers de l'Enfant (SFCE) from 2000 to 2013. Int J Radiat Oncol Biol Phys, 102(1), 166-173. doi:10.1016/j.ijrobp.2018.05.036

Duffau, H. (2005). Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity. Lancet Neurol, 4(8), 476-486. doi:10.1016/S1474-4422(05)70140-X

Eekers, D. B., In 't Ven, L., Roelofs, E., Postma, A., Alapetite, C., Burnet, N. G., . . . Troost, E. G. C. (2018). The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology. Radiother Oncol, 128(1), 37-43. doi:10.1016/j.radonc.2017.12.013

Elliott, R. E., Parker, E. C., Rush, S. C., Kalhorn, S. P., Moshel, Y. A., Narayana, A., . . . Golfinos, J. G. (2011). Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection. World Neurosurg, 76(1-2), 128-140; discussion 161-122. doi:10.1016/j.wneu.2010.12.053

Ellison, D. W., Dalton, J., Kocak, M., Nicholson, S. L., Fraga, C., Neale, G., . . . Gilbertson, R. J. J. A. N. (2011). Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. 121(3), 381-396. doi:10.1007/s00401-011-0800-8

Ellison, D. W., Onilude, O. E., Lindsey, J. C., Lusher, M. E., Weston, C. L., Taylor, R. E., . . . Clifford, S. C. (2005). beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol, 23(31), 7951-7957. doi:10.1200/jco.2005.01.5479

Englot, D. J., Berger, M. S., Barbaro, N. M., & Chang, E. F. (2011). Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg, 115(2), 240-244. doi:10.3171/2011.3.JNS1153

Eriksson, M., Kahari, J., Vestman, A., Hallmans, M., Johansson, M., Bergenheim, A. T., & Sandstrom, M. (2019). Improved treatment of glioblastoma - changes in survival over two decades at a single regional Centre. Acta Oncol, 58(3), 334-341. doi:10.1080/0284186x.2019.1571278

Ernst-Stecken, A., Ganslandt, O., Lambrecht, U., Sauer, R., & Grabenbauer, G. (2007). Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma. J Neurooncol, 81(3), 287-294. doi:10.1007/s11060-006-9231-0

Esposito, S., Tenconi, R., Preti, V., Groppali, E., & Principi, N. (2016). Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes. Medicine (Baltimore), 95(38), e4899. doi:10.1097/MD.0000000000004899

Eustachi, A., & Melchart, D. (2017). [Complementary and Alternative Medicine in Oncology - What Makes Sense?]. Dtsch Med Wochenschr, 142(12), 882-888. doi:10.1055/s-0042-121882

Faithfull, S., Cook, K., & Lucas, C. (2005). Palliative care of patients with a primary malignant brain tumour: case review of service use and support provided. Palliat Med, 19(7), 545-550. doi:10.1191/0269216305pm1068oa

Fakhreddine, M. H., Mahajan, A., Penas-Prado, M., Weinberg, J., McCutcheon, I. E., Puduvalli, V., & Brown, P. D. (2013). Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. Neuro Oncol, 15(4), 406-412. doi:10.1093/neuonc/nos309

Farschtschi, S., Merker, V. L., Wolf, D., Schuhmann, M., Blakeley, J., Plotkin, S. R., . . . Mautner, V. F. (2016). Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2. Acta Neurol Scand, 133(6), 475-480. doi:10.1111/ane.12490

FASS, Vårdpersonal. Retrieved from http://www.fass.se/LIF/startpage?userType=0

Fass, Vårdpersonal. Betametason Alternova Retrieved from https://www.fass.se/LIF/product?nplId=20140823000062&userType=0

Felini, M. J., Olshan, A. F., Schroeder, J. C., Carozza, S. E., Miike, R., Rice, T., & Wrensch, M. (2009). Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control, 20(1), 87-96. doi:10.1007/s10552-008-9220-z

Fetcko, K., & Dey, M. (2018). Primary Central Nervous System Germ Cell Tumors: A Review and Update. Med Res Arch, 6(3). doi:10.18103/mra.v6i3.1719

Fisher, B. J., Hu, C., Macdonald, D. R., Lesser, G. J., Coons, S. W., Brachman, D. G., . . . Mehta, M. (2015). Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424. Int J Radiat Oncol Biol Phys, 91(3), 497-504. doi:10.1016/j.ijrobp.2014.11.012

Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., . . . Wiebe, S. (2014). ILAE official report: a practical clinical definition of epilepsy. Epilepsia, 55(4), 475-482. doi:10.1111/epi.12550

Flechl, B., Hassler, M. R., Kopetzky, G., Balcke, P., Kurz, C., & Marosi, C. (2013). Case Report: Pregnancy in a patient with recurrent glioblastoma. F1000Res, 2, 246. doi:10.12688/f1000research.2-246.v1

Fogh, S. E., Andrews, D. W., Glass, J., Curran, W., Glass, C., Champ, C., . . . Werner-Wasik, M. (2010). Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol, 28(18), 3048-3053. doi:10.1200/JCO.2009.25.6941

Forsgren, L. (2016). Epilepsiboken.

Fouladi, M., Stewart, C. F., Blaney, S. M., Onar-Thomas, A., Schaiquevich, P., Packer, R. J., . . . Gilbertson, R. J. (2010). Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study. J Clin Oncol, 28(27), 4221-4227. doi:10.1200/jco.2010.28.4687

Friedman, H. S., Prados, M. D., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., . . . Cloughesy, T. (2009). Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol, 27(28), 4733-4740. doi:10.1200/JCO.2008.19.8721

Friedrich, C., von Bueren, A. O., von Hoff, K., Kwiecien, R., Pietsch, T., Warmuth-Metz, M., . . . Rutkowski, S. (2013). Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. Eur J Cancer, 49(4), 893-903. doi:10.1016/j.ejca.2012.10.006

FYSS (2018). Ryggmärgsskada. . (2018). Retrieved from http://www.fyss.se/wp-content/uploads/2018/02/41.-Ryggm%C3%A4rgsskada.pdf

FYSS. Fysisk aktivitet i sjukdomsprevention och sjukdomsbehandling. (2015). Retrieved from http://www.fyss.se/fyss-kapitel/fyss-kapitel-del-2-diagnosspecifik-del/

Gajjar, A., Reaman, G. H., Racadio, J. M., & Smith, F. O. (2018). Brain Tumors in Children. Cham: Springer International Publishing :.

Galldiks, N., Law, I., Pope, W. B., Arbizu, J., & Langen, K. J. (2017). The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy. Neuroimage Clin, 13, 386-394. doi:10.1016/j.nicl.2016.12.020

Gao, Y., Jiang, J., & Liu, Q. (2014). Clinicopathological and immunohistochemical features of primary central nervous system germ cell tumors: a 24-years experience. Int J Clin Exp Pathol, 7(10), 6965-6972.

Geer, C. P., Simonds, J., Anvery, A., Chen, M. Y., Burdette, J. H., Zapadka, M. E., . . . Johnson, A. J. (2012). Does MR perfusion imaging impact management decisions for patients with brain tumors? A prospective study. AJNR Am J Neuroradiol, 33(3), 556-562. doi:10.3174/ajnr.A2811

Gehring, K., Aaronson, N. K., Gundy, C. M., Taphoorn, M. J., & Sitskoorn, M. M. (2011). Predictors of neuropsychological improvement following cognitive rehabilitation in patients with gliomas. J Int Neuropsychol Soc, 17(2), 256-266. doi:10.1017/S1355617710001530

Gehring, K., Sitskoorn, M. M., Aaronson, N. K., & Taphoorn, M. J. (2008). Interventions for cognitive deficits in adults with brain tumours. Lancet Neurol, 7(6), 548-560. doi:10.1016/S1474-4422(08)70111-X

Gehring, K., Sitskoorn, M. M., Gundy, C. M., Sikkes, S. A., Klein, M., Postma, T. J., . . . Aaronson, N. K. (2009). Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol, 27(22), 3712-3722. doi:10.1200/JCO.2008.20.5765

Geler-Kulcu, D., Gulsen, G., Buyukbaba, E., & Ozkan, D. (2009). Functional recovery of patients with brain tumor or acute stroke after rehabilitation: a comparative study. J Clin Neurosci, 16(1), 74-78. doi:10.1016/j.jocn.2008.04.014

Gerstner, E. R., & Pajtler, K. W. (2018). Ependymoma. Semin Neurol, 38(1), 104-111. doi:10.1055/s-0038-1636503

Gessi, M., Giagnacovo, M., Modena, P., Elefante, G., Gianno, F., Buttarelli, F. R., . . . Antonelli, M. (2019). Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology. Am J Surg Pathol, 43(1), 56-63. doi:10.1097/pas.0000000000000979

Gilbert, M., Yuan, Y., Wani, K., Wu, J., Omuro, A., Lieberman, F., . . . Aldape, K. (2014). AT-23: A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL. Neuro-Oncology, 16(Suppl 5), v13-v13. doi:10.1093/neuonc/nou237.23

Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., . . . Mehta, M. P. (2014). A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med, 370(8), 699-708. doi:10.1056/NEJMoa1308573

Gilbert, M. R., Wang, M., Aldape, K. D., Stupp, R., Hegi, M. E., Jaeckle, K. A., . . . Mehta, M. P. (2013). Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol, 31(32), 4085-4091. doi:10.1200/JCO.2013.49.6968

Gill, P., Litzow, M., Buckner, J., Arndt, C., Moynihan, T., Christianson, T., . . . Galanis, E. (2008). High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system. Cancer, 112(8), 1805-1811. doi:10.1002/cncr.23362

Giordana, M. T., & Clara, E. (2006). Functional rehabilitation and brain tumour patients. A review of outcome. Neurol Sci, 27(4), 240-244. doi:10.1007/s10072-006-0677-9

Glauser, T., Ben-Menachem, E., Bourgeois, B., Cnaan, A., Guerreiro, C., Kalviainen, R., . . . Guidelines, I. S. o. A. (2013). Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia, 54(3), 551-563. doi:10.1111/epi.12074

Gorlia, T., Wu, W., Wang, M., Baumert, B. G., Mehta, M., Buckner, J. C., . . . van den Bent, M. J. (2013). New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Neuro Oncol, 15(11), 1568-1579. doi:10.1093/neuonc/not117

Gottberg, K. (2015). Omvårdnad vid neurologiska sjukdomar. Lund: Studentlitteratur.

Gramatzki, D., Kickingereder, P., Hentschel, B., Felsberg, J., Herrlinger, U., Schackert, G., . . . Weller, M. (2017). Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma. Neurology, 88(15), 1422-1430. doi:10.1212/WNL.0000000000003809

Gramatzki, D., Roth, P., Felsberg, J., Hofer, S., Rushing, E. J., Hentschel, B., . . . Weller, M. (2016). Chemotherapy for intracranial ependymoma in adults. BMC Cancer, 16, 287. doi:10.1186/s12885-016-2323-0

Green, R. M., Cloughesy, T. F., Stupp, R., DeAngelis, L. M., Woyshner, E. A., Ney, D. E., & Lassman, A. B. (2009). Bevacizumab for recurrent ependymoma. Neurology, 73(20), 1677-1680. doi:10.1212/WNL.0b013e3181c1df34

Greene-Schloesser, D., Moore, E., & Robbins, M. E. (2013). Molecular pathways: radiation-induced cognitive impairment. Clin Cancer Res, 19(9), 2294-2300. doi:10.1158/1078-0432.CCR-11-2903

Greene-Schloesser, D., Robbins, M. E., Peiffer, A. M., Shaw, E. G., Wheeler, K. T., & Chan, M. D. (2012). Radiation-induced brain injury: A review. Front Oncol, 2, 73. doi:10.3389/fonc.2012.00073

Grunfeld, E., Coyle, D., Whelan, T., Clinch, J., Reyno, L., Earle, C. C., . . . Glossop, R. (2004). Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ, 170(12), 1795-1801.

Halkett, G. K., Lobb, E. A., Oldham, L., & Nowak, A. K. (2010). The information and support needs of patients diagnosed with High Grade Glioma. Patient Educ Couns, 79(1), 112-119. doi:10.1016/j.pec.2009.08.013

Han, S. J., Rolston, J. D., Molinaro, A. M., Clarke, J. L., Prados, M. D., Chang, S. M., . . . Butowski, N. A. (2014). Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma. Neuro Oncol, 16(9), 1255-1262. doi:10.1093/neuonc/nou044

Hansen, A., Sogaard, K., Minet, L. R., & Jarden, J. O. (2018). A 12-week interdisciplinary rehabilitation trial in patients with gliomas - a feasibility study. Disabil Rehabil, 40(12), 1379-1385. doi:10.1080/09638288.2017.1295472

Happold, C., Gorlia, T., Chinot, O., Gilbert, M. R., Nabors, L. B., Wick, W., . . . Weller, M. (2016). Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma. J Clin Oncol, 34(7), 731-739. doi:10.1200/JCO.2015.63.6563

Haque, W., Verma, V., Butler, E. B., & Teh, B. S. (2017). Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma. J Neurooncol, 133(2), 369-375. doi:10.1007/s11060-017-2443-7

Harrison, R. A., Kesler, S. R., Johnson, J. M., Penas-Prado, M., Sullaway, C. M., & Wefel, J. S. (2019). Neurocognitive dysfunction in adult cerebellar medulloblastoma. Psychooncology, 28(1), 131-138. doi:10.1002/pon.4920

Harrop, J. S., Ganju, A., Groff, M., & Bilsky, M. (2009). Primary intramedullary tumors of the spinal cord. Spine (Phila Pa 1976), 34(22 Suppl), S69-77. doi:10.1097/BRS.0b013e3181b95c6f

Hassler, M. R., Elandt, K., Preusser, M., Lehrner, J., Binder, P., Dieckmann, K., . . . Marosi, C. (2010). Neurocognitive training in patients with high-grade glioma: a pilot study. J Neurooncol, 97(1), 109-115. doi:10.1007/s11060-009-0006-2

Hatch, E. E., Linet, M. S., Zhang, J., Fine, H. A., Shapiro, W. R., Selker, R. G., . . . Inskip, P. D. (2005). Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer, 114(5), 797-805. doi:10.1002/ijc.20776

Heiland, D. H., Masalha, W., Franco, P., Machein, M. R., & Weyerbrock, A. (2016). Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine. J Neurooncol, 126(3), 567-575. doi:10.1007/s11060-015-2002-z

Heister Trygg, B. (1998). Alternativ och kompletterande kommunikation (AKK) i teori och praktik. Vällingby: Handikappinstitutet.

Hellbom, M., & Thomé, B. (2011). Perspektiv på onkologisk vård. Lund: Studentlitteratur.

Herholz, K., Holzer, T., Bauer, B., Schroder, R., Voges, J., Ernestus, R. I., . . . Heiss, W. D. (1998). 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology, 50(5), 1316-1322.

Herrlinger, U., Tzaridis, T., Mack, F., Steinbach, J. P., Schlegel, U., Sabel, M., . . . Glas, M. (2019). Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. Lancet, 393(10172), 678-688. doi:10.1016/s0140-6736(18)31791-4

Hervey-Jumper, S. L., & Berger, M. S. (2014). Reoperation for recurrent high-grade glioma: a current perspective of the literature. Neurosurgery, 75(5), 491-499; discussion 498-499. doi:10.1227/NEU.0000000000000486

Hippocampal Sparing Retrieved from https://www.rtog.org/CoreLab/ContouringAtlases/HippocampalSparing.aspx

Ho, E. S. Q., Barrett, S. A., & Mullaney, L. M. (2017). A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma. Acta Oncol, 56(8), 1031-1042. doi:10.1080/0284186x.2017.1324207

Hoang-Xuan, K., Capelle, L., Kujas, M., Taillibert, S., Duffau, H., Lejeune, J., . . . Delattre, J. Y. (2004). Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol, 22(15), 3133-3138. doi:10.1200/JCO.2004.10.169

Hoff, K. V., Hinkes, B., Gerber, N. U., Deinlein, F., Mittler, U., Urban, C., . . . Rutkowski, S. (2009). Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. Eur J Cancer, 45(7), 1209-1217. doi:10.1016/j.ejca.2009.01.015

https://lakemedelsboken.se/kapitel/gynekologi/allman_gynekologi.html.

Huang, K., Whelan, E. A., Ruder, A. M., Ward, E. M., Deddens, J. A., Davis-King, K. E., . . . Brain Cancer Collaborative Study, G. (2004). Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev, 13(10), 1583-1588.

Hubbard, J. L., Scheithauer, B. W., Kispert, D. B., Carpenter, S. M., Wick, M. R., & Laws, E. R., Jr. (1989). Adult cerebellar medulloblastomas: the pathological, radiographic, and clinical disease spectrum. J Neurosurg, 70(4), 536-544. doi:10.3171/jns.1989.70.4.0536

Hudes, R. S., Corn, B. W., Werner-Wasik, M., Andrews, D., Rosenstock, J., Thoron, L., . . . Curran, W. J., Jr. (1999). A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys, 43(2), 293-298.

Indelicato, D. J., Bradley, J. A., Rotondo, R. L., Nanda, R. H., Logie, N., Sandler, E. S., . . . Mendenhall, N. P. (2018). Outcomes following proton therapy for pediatric ependymoma. Acta Oncol, 57(5), 644-648. doi:10.1080/0284186x.2017.1413248

An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma (SIOP-EP-II). NCT02265770. (2019). Retrieved from https://clinicaltrials.gov/ct2/show/NCT02265770

Iqbal, M. S., & Lewis, J. (2013). An overview of the management of adult ependymomas with emphasis on relapsed disease. Clin Oncol (R Coll Radiol), 25(12), 726-733. doi:10.1016/j.clon.2013.07.009

Isaacson, S. R. (2000). Radiation therapy and the management of intramedullary spinal cord tumors. J Neurooncol, 47(3), 231-238.

Isaksson, J., Lilliehorn, S., & Salander, P. (2018). Cancer patients' motives for psychosocial consultation-Oncology social workers' perceptions of 226 patient cases. Psychooncology, 27(4), 1180-1184. doi:10.1002/pon.4633

Isaksson, J., Lilliehorn, S., & Salander, P. (2019). Next of kin's motives for psychosocial consultation-Oncology social workers' perceptions of 54 next of kin cases. Psychooncology, 28(1), 154-159. doi:10.1002/pon.4925

Isaksson, J., Salander, P., Lilliehorn, S., & Laurell, G. (2016). Living an everyday life with head and neck cancer 2-2.5 years post-diagnosis - A qualitative prospective study of 56 patients. Soc Sci Med, 154, 54-61. doi:10.1016/j.socscimed.2016.02.031

Ishkanian, A., Laperriere, N. J., Xu, W., Millar, B. A., Payne, D., Mason, W., & Sahgal, A. (2011). Upfront observation versus radiation for adult pilocytic astrocytoma. Cancer, 117(17), 4070-4079. doi:10.1002/cncr.25988

Jaeckle et al. CODEL (Alliance-N0577; EORTC-26081/22086; NRG-1071; NCIC-CEC-2): Phase III Randomized Study of RT vs. RT+TMZ vs. TMZ for Newly Diagnosed 1p/19q-Codeleted Anaplastic Oligodendroglial Tumors. Analysis of Patients Treated on the Original Protocol Design (PL02.005)Neurology April 5, 2016 vol. 86 no. 16 Supplement PL02.005.

Jaeckle, K., Vogelbaum, M., Ballman, K., Anderson, S. K., Giannini, C., Aldape, K., . . . Brown, P. (2016). CODEL (Alliance-N0577; EORTC-26081/22086; NRG-1071; NCIC-CEC-2): Phase III Randomized Study of RT vs. RT+TMZ vs. TMZ for Newly Diagnosed 1p/19q-Codeleted Anaplastic Oligodendroglial Tumors. Analysis of Patients Treated on the Original Protocol Design (PL02.005). Neurology, 86(16 Supplement), PL02.005.

Jakola, A. S., Myrmel, K. S., Kloster, R., Torp, S. H., Lindal, S., Unsgard, G., & Solheim, O. (2012). Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA, 308(18), 1881-1888. doi:10.1001/jama.2012.12807

Jansen, E. P., Dewit, L. G., van Herk, M., & Bartelink, H. (2000). Target volumes in radiotherapy for high-grade malignant glioma of the brain. Radiother Oncol, 56(2), 151-156.

Johansson, B., & Rönnbäck, L. (2014). När hjärnan inte orkar : om hjärntrötthet. Sandared: Recito.

Johnson, D. R., Brown, P. D., Galanis, E., & Hammack, J. E. (2012). Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. J Neurooncol, 108(1), 187-193. doi:10.1007/s11060-012-0829-0

Jung, J., Choi, W., Ahn, S. D., Park, J. H., Kim, S. S., Kim, Y. S., . . . Choi, E. K. (2012). Postoperative radiotherapy for ependymoma. Radiat Oncol J, 30(4), 158-164. doi:10.3857/roj.2012.30.4.158

Kabat, G. C., Park, Y., Hollenbeck, A. R., Schatzkin, A., & Rohan, T. E. (2011). Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study. Int J Cancer, 128(4), 944-950. doi:10.1002/ijc.25413

Kakkar, A., Biswas, A., Kalyani, N., Chatterjee, U., Suri, V., Sharma, M. C., . . . Sarkar, C. (2016). Intracranial germ cell tumors: a multi-institutional experience from three tertiary care centers in India. Childs Nerv Syst, 32(11), 2173-2180. doi:10.1007/s00381-016-3167-2

Kaloshi, G., Psimaras, D., Mokhtari, K., Dehais, C., Houillier, C., Marie, Y., . . . Delattre, J. Y. (2009). Supratentorial low-grade gliomas in older patients. Neurology, 73(24), 2093-2098. doi:10.1212/WNL.0b013e3181c6781e

Kann, B. H., Lester-Coll, N. H., Park, H. S., Yeboa, D. N., Kelly, J. R., Baehring, J. M., . . . Roberts, K. B. (2017). Adjuvant chemotherapy and overall survival in adult medulloblastoma. Neuro Oncol, 19(2), 259-269. doi:10.1093/neuonc/now150

Karim, A. B., Maat, B., Hatlevoll, R., Menten, J., Rutten, E. H., Thomas, D. G., . . . van Glabbeke, M. (1996). A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys, 36(3), 549-556.

Keime-Guibert, F., Chinot, O., Taillandier, L., Cartalat-Carel, S., Frenay, M., Kantor, G., . . . Delattre, J. Y. (2007). Radiotherapy for glioblastoma in the elderly. N Engl J Med, 356(15), 1527-1535. doi:10.1056/NEJMoa065901

Kerkhof, M., Dielemans, J. C., van Breemen, M. S., Zwinkels, H., Walchenbach, R., Taphoorn, M. J., & Vecht, C. J. (2013). Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro Oncol, 15(7), 961-967. doi:10.1093/neuonc/not057

Kerkhof, M., Koekkoek, J. A. F., Vos, M. J., van den Bent, M. J., Taal, W., Postma, T. J., . . . Taphoorn, M. J. B. (2019). Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study. J Neurooncol, 142(3), 463-470. doi:10.1007/s11060-019-03117-y

Kesari, S., Schiff, D., Drappatz, J., LaFrankie, D., Doherty, L., Macklin, E. A., . . . Wen, P. Y. (2009). Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res, 15(1), 330-337. doi:10.1158/1078-0432.CCR-08-0888

Keulers, B. J., Scheltinga, M. R., Houterman, S., Van Der Wilt, G. J., & Spauwen, P. H. (2008). Surgeons underestimate their patients' desire for preoperative information. World J Surg, 32(6), 964-970. doi:10.1007/s00268-008-9581-1

Kieran, M. W., Chisholm, J., Casanova, M., Brandes, A. A., Aerts, I., Bouffet, E., . . . Geoerger, B. (2017). Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma. Neuro Oncol, 19(11), 1542-1552. doi:10.1093/neuonc/nox109

Kim, B. R., Chun, M. H., Han, E. Y., & Kim, D. K. (2012). Fatigue assessment and rehabilitation outcomes in patients with brain tumors. Support Care Cancer, 20(4), 805-812. doi:10.1007/s00520-011-1153-5

Kim, H. K., Thornton, A. F., Greenberg, H. S., Page, M. A., Junck, L., & Sandler, H. M. (1997). Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy. Am J Clin Oncol, 20(4), 358-363.

Kim, J. Y., & Park, J. (2015). Understanding the Treatment Strategies of Intracranial Germ Cell Tumors: Focusing on Radiotherapy. J Korean Neurosurg Soc, 57(5), 315-322. doi:10.3340/jkns.2015.57.5.315

Kirkpatrick, J. P., van der Kogel, A. J., & Schultheiss, T. E. (2010). Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys, 76(3 Suppl), S42-49. doi:10.1016/j.ijrobp.2009.04.095

Kita, M., Okawa, T., Tanaka, M., & Ikeda, M. (1989). [Radiotherapy of malignant glioma--prospective randomized clinical study of whole brain vs local irradiation]. Gan No Rinsho, 35(11), 1289-1294.

Kleinschmidt-DeMasters, B. K., Aisner, D. L., Birks, D. K., & Foreman, N. K. (2013). Epithelioid GBMs show a high percentage of BRAF V600E mutation. Am J Surg Pathol, 37(5), 685-698. doi:10.1097/PAS.0b013e31827f9c5e

Kleinschmidt-DeMasters, B. K., Aisner, D. L., & Foreman, N. K. (2015). BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation. Am J Surg Pathol, 39(4), 528-540. doi:10.1097/PAS.0000000000000363

Kocakaya, S., Beier, C. P., & Beier, D. (2016). Chemotherapy increases long-term survival in patients with adult medulloblastoma--a literature-based meta-analysis. Neuro Oncol, 18(3), 408-416. doi:10.1093/neuonc/nov185

Koekkoek, J. A., Dirven, L., Heimans, J. J., Postma, T. J., Vos, M. J., Reijneveld, J. C., & Taphoorn, M. J. (2015). Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide. J Neurol Neurosurg Psychiatry, 86(4), 366-373. doi:10.1136/jnnp-2014-308136

Koekkoek, J. A., Kerkhof, M., Dirven, L., Heimans, J. J., Reijneveld, J. C., & Taphoorn, M. J. (2015). Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review. Neuro Oncol, 17(7), 924-934. doi:10.1093/neuonc/nov032

Kortmann, R. D., Kuhl, J., Timmermann, B., Mittler, U., Urban, C., Budach, V., . . . Bamberg, M. (2000). Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys, 46(2), 269-279. doi:10.1016/s0360-3016(99)00369-7

Kracht, L. W., Miletic, H., Busch, S., Jacobs, A. H., Voges, J., Hoevels, M., . . . Heiss, W. D. (2004). Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res, 10(21), 7163-7170. doi:10.1158/1078-0432.CCR-04-0262

Krishnamachari, B., Il'yasova, D., Scheurer, M. E., Bondy, M. L., Wrensch, M., & Davis, F. G. (2014). A pooled multisite analysis of the effects of female reproductive hormones on glioma risk. Cancer Causes Control, 25(8), 1007-1013. doi:10.1007/s10552-014-0400-8

Kristiansen, K., Hagen, S., Kollevold, T., Torvik, A., Holme, I., Nesbakken, R., . . . Elgen, K. (1981). Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer, 47(4), 649-652.

Kunschner, L. J., Kuttesch, J., Hess, K., & Yung, W. K. (2001). Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro Oncol, 3(3), 167-173. doi:10.1093/neuonc/3.3.167

Kvalitetsregisterrapporter för hjärntumörer. Retrieved from https://www.cancercentrum.se/samverkan/cancerdiagnoser/hjarna-ryggmarg-och-hypofys/hjarna-och-ryggmarg/kvalitetsregister/rapporter/

Lacroix, M., Abi-Said, D., Fourney, D. R., Gokaslan, Z. L., Shi, W., DeMonte, F., . . . Sawaya, R. (2001). A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg, 95(2), 190-198. doi:10.3171/jns.2001.95.2.0190

Lannering, B., Rutkowski, S., Doz, F., Pizer, B., Gustafsson, G., Navajas, A., . . . Kortmann, R. (2012). Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol, 30(26), 3187-3193. doi:10.1200/jco.2011.39.8719

Laperriere, N., Zuraw, L., Cairncross, G., & Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site, G. (2002). Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol, 64(3), 259-273.

Larson, D. A., Prados, M., Lamborn, K. R., Smith, V., Sneed, P. K., Chang, S., . . . McDermott, M. W. (2002). Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma. Int J Radiat Oncol Biol Phys, 54(5), 1397-1404.

Lassman, A. B., Iwamoto, F. M., Cloughesy, T. F., Aldape, K. D., Rivera, A. L., Eichler, A. F., . . . Panageas, K. S. (2011). International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol, 13(6), 649-659. doi:10.1093/neuonc/nor040

Lawrence, Y. R., Li, X. A., el Naqa, I., Hahn, C. A., Marks, L. B., Merchant, T. E., & Dicker, A. P. (2010). Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys, 76(3 Suppl), S20-27. doi:10.1016/j.ijrobp.2009.02.091

Lebrun, C., Fontaine, D., Bourg, V., Ramaioli, A., Chanalet, S., Vandenbos, F., . . . Frenay, M. (2007). Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy. Eur J Neurol, 14(4), 391-398. doi:10.1111/j.1468-1331.2007.01675.x

Lee, K. J., Marchan, E., Peterson, J., Harrell, A. C., Quinones-Hinojosa, A., Brown, P. D., & Trifiletti, D. M. (2018). Management and Survival of Adult Patients with Pilocytic Astrocytoma in the National Cancer Database. World Neurosurg, 112, e881-e887. doi:10.1016/j.wneu.2018.01.208

Lee, S. W., Fraass, B. A., Marsh, L. H., Herbort, K., Gebarski, S. S., Martel, M. K., . . . Sandler, H. M. (1999). Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys, 43(1), 79-88.

Lefebvre, L., Doyeux, K., Linca, S., Challand, T., & Hanzen, C. (2014). [Radiotherapy of a glioma in a pregnant woman: evaluation of the foetal dose in conformational 3D or intensity-modulated]. Cancer Radiother, 18(8), 763-766. doi:10.1016/j.canrad.2014.07.158

Leu, S., von Felten, S., Frank, S., Vassella, E., Vajtai, I., Taylor, E., . . . Mariani, L. (2013). IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival. Neuro Oncol, 15(4), 469-479. doi:10.1093/neuonc/nos317

Levin, N., Gomori, J. M., & Siegal, T. (2004). Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide. Neurology, 63(2), 354-356.

Levin, N., Lavon, I., Zelikovitsh, B., Fuchs, D., Bokstein, F., Fellig, Y., & Siegal, T. (2006). Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression. Cancer, 106(8), 1759-1765. doi:10.1002/cncr.21809

Li, H., Li, J., Cheng, G., Zhang, J., & Li, X. (2016). IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy. Clin Neurol Neurosurg, 151, 31-36. doi:10.1016/j.clineuro.2016.10.004

Liang, S. Y., Yang, T. F., Chen, Y. W., Liang, M. L., Chen, H. H., Chang, K. P., . . . Wong, T. T. (2013). Neuropsychological functions and quality of life in survived patients with intracranial germ cell tumors after treatment. Neuro Oncol, 15(11), 1543-1551. doi:10.1093/neuonc/not127

Lilliehorn, S., Hamberg, K., Kero, A., & Salander, P. (2010). 'Admission into a helping plan': a watershed between positive and negative experiences in breast cancer. Psychooncology, 19(8), 806-813. doi:10.1002/pon.1619

Lim, G., Ho, C., Roldan Urgoti, G., Leugner, D., & Easaw, J. (2018). Risk of Venous Thromboembolism in Glioblastoma Patients. Cureus, 10(5), e2678. doi:10.7759/cureus.2678

Lithner, M. and T. Zilling, Does preoperative information increase the wellbeing of the patient after surgery? (in Swedish). Vård i Norden 1998; 18:31-33,39, 1998.

Liu, R., Solheim, K., Polley, M. Y., Lamborn, K. R., Page, M., Fedoroff, A., . . . Chang, S. M. (2009). Quality of life in low-grade glioma patients receiving temozolomide. Neuro Oncol, 11(1), 59-68. doi:10.1215/15228517-2008-063

Liu, X. Y., Gerges, N., Korshunov, A., Sabha, N., Khuong-Quang, D. A., Fontebasso, A. M., . . . Jabado, N. (2012). Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations. Acta Neuropathol, 124(5), 615-625. doi:10.1007/s00401-012-1031-3

Lofvander, M., Ahlbeck, K., & Lindell, O. (2009). [Neuropathic pain can be handled in ten minutes]. Lakartidningen, 106(4), 212-213.

Louis D. N., O. H., Wiestler O. D., Cavenee W. K. (2016). WHO Classification of Tumours of the Central Nervous System. WHO/IARC Classification of Tumours, 4th Edition Revised.

Louis, D. N., Aldape, K., Brat, D. J., Capper, D., Ellison, D. W., Hawkins, C., . . . von Deimling, A. J. A. N. (2017). Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy. 133(1), 1-3. doi:10.1007/s00401-016-1646-x

Louis, D. N., Giannini, C., Capper, D., Paulus, W., Figarella-Branger, D., Lopes, M. B., . . . Wesseling, P. (2018). cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol, 135(4), 639-642. doi:10.1007/s00401-018-1826-y

Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., . . . Ellison, D. W. (2016). The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol, 131(6), 803-820. doi:10.1007/s00401-016-1545-1

Louis, D. N., Wesseling, P., Paulus, W., Giannini, C., Batchelor, T. T., Cairncross, J. G., . . . van den Bent, M. (2018). cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC). Acta Neuropathol, 135(3), 481-484. doi:10.1007/s00401-018-1808-0

Lutterbach, J., Pagenstecher, A., Spreer, J., Hetzel, A., Velthoven, V., Nikkhah, G., . . . Ostertag, C. (2005). The brain tumor board: lessons to be learned from an interdisciplinary conference. Onkologie, 28(1), 22-26. doi:10.1159/000082124

Lutz, K., Radbruch, A., Wiestler, B., Baumer, P., Wick, W., & Bendszus, M. (2011). Neuroradiological response criteria for high-grade gliomas. Clin Neuroradiol, 21(4), 199-205. doi:10.1007/s00062-011-0080-7

Mabbott, D. J., Monsalves, E., Spiegler, B. J., Bartels, U., Janzen, L., Guger, S., . . . Bouffet, E. (2011). Longitudinal evaluation of neurocognitive function after treatment for central nervous system germ cell tumors in childhood. Cancer, 117(23), 5402-5411. doi:10.1002/cncr.26127

Mackenzie, A. P., Levine, G., Garry, D., & Figueroa, R. (2005). Glioblastoma multiforme in pregnancy. J Matern Fetal Neonatal Med, 17(1), 81-83. doi:10.1080/14767050400028709

Madsen, K., & Poulsen, H. S. (2011). Needs for everyday life support for brain tumour patients' relatives: systematic literature review. Eur J Cancer Care (Engl), 20(1), 33-43. doi:10.1111/j.1365-2354.2010.01184.x

Malekzadeh F. et al. Naturläkemedel och hormonpreparat - potentiell risk för bröstcancerpatienter. (2005). Retrieved from http://www.lakartidningen.se/Functions/OldArticleView.aspx?articleId=2396

Malmer, B., Iselius, L., Holmberg, E., Collins, A., Henriksson, R., & Gronberg, H. (2001). Genetic epidemiology of glioma. Br J Cancer, 84(3), 429-434. doi:10.1054/bjoc.2000.1612

Malmstrom, A., Gronberg, B. H., Marosi, C., Stupp, R., Frappaz, D., Schultz, H., . . . Nordic Clinical Brain Tumour Study, G. (2012). Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol, 13(9), 916-926. doi:10.1016/S1470-2045(12)70265-6

Malmstrom, A., Poulsen, H. S., Gronberg, B. H., Stragliotto, G., Hansen, S., Asklund, T., . . . Nordic Clinical Brain Tumor Study, G. (2017). Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial. Acta Oncol, 1-10. doi:10.1080/0284186X.2017.1332780

Mandonnet, E., Delattre, J. Y., Tanguy, M. L., Swanson, K. R., Carpentier, A. F., Duffau, H., . . . Capelle, L. (2003). Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol, 53(4), 524-528. doi:10.1002/ana.10528

Mansur, D. B., Drzymala, R. E., Rich, K. M., Klein, E. E., & Simpson, J. R. (2004). The efficacy of stereotactic radiosurgery in the management of intracranial ependymoma. J Neurooncol, 66(1-2), 187-190.

Maschio, M., Zarabla, A., Maialetti, A., Fabi, A., Vidiri, A., Villani, V., & Giannarelli, D. (2017). Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group. Epilepsy Behav, 73, 83-89. doi:10.1016/j.yebeh.2017.05.031

Massimino, M., Gandola, L., Giangaspero, F., Sandri, A., Valagussa, P., Perilongo, G., . . . Madon, E. (2004). Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Int J Radiat Oncol Biol Phys, 58(5), 1336-1345. doi:10.1016/j.ijrobp.2003.08.030

Matsutani, M. (2001). Combined chemotherapy and radiation therapy for CNS germ cell tumors--the Japanese experience. J Neurooncol, 54(3), 311-316.

Matsutani, M., Sano, K., Takakura, K., Fujimaki, T., Nakamura, O., Funata, N., & Seto, T. (1997). Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg, 86(3), 446-455. doi:10.3171/jns.1997.86.3.0446

Mayer, R., & Sminia, P. (2008). Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys, 70(5), 1350-1360. doi:10.1016/j.ijrobp.2007.08.015

Mazonakis, M., & Damilakis, J. (2017). Estimation and reduction of the radiation dose to the fetus from external-beam radiotherapy. Phys Med. doi:10.1016/j.ejmp.2017.09.130

McCarthy, B. J., Shibui, S., Kayama, T., Miyaoka, E., Narita, Y., Murakami, M., . . . Villano, J. L. (2012). Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro Oncol, 14(9), 1194-1200. doi:10.1093/neuonc/nos155

McInnes, E., Jammali-Blasi, A., Bell-Syer, S. E., Dumville, J. C., Middleton, V., & Cullum, N. (2015). Support surfaces for pressure ulcer prevention. Cochrane Database Syst Rev(9), Cd001735. doi:10.1002/14651858.CD001735.pub5

Medical Research Council Brain Tumor Working, P. (2001). Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J Clin Oncol, 19(2), 509-518.

Melin, B. S., Barnholtz-Sloan, J. S., Wrensch, M. R., Johansen, C., Il'yasova, D., Kinnersley, B., . . . Bondy, M. L. (2017). Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat Genet, 49(5), 789-794. doi:10.1038/ng.3823

Merchant, T. E., Li, C., Xiong, X., Kun, L. E., Boop, F. A., & Sanford, R. A. (2009). Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol, 10(3), 258-266.

Messini, C. I., Daponte, A., Anifandis, G., Mahmood, T., & Messinis, I. E. (2016). Standards of Care in infertility in Europe. Eur J Obstet Gynecol Reprod Biol. doi:10.1016/j.ejogrb.2016.10.003

Metellus, P., Guyotat, J., Chinot, O., Durand, A., Barrie, M., Giorgi, R., . . . Figarella-Branger, D. (2010). Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients. Neuro Oncol, 12(9), 976-984. doi:10.1093/neuonc/noq047

Meyronet, D., Esteban-Mader, M., Bonnet, C., Joly, M. O., Uro-Coste, E., Amiel-Benouaich, A., . . . Ducray, F. (2017). Characteristics of H3 K27M-mutant gliomas in adults. Neuro Oncol, 19(8), 1127-1134. doi:10.1093/neuonc/now274

Michaud, D. S., Gallo, V., Schlehofer, B., Tjonneland, A., Olsen, A., Overvad, K., . . . Riboli, E. (2010). Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev, 19(10), 2562-2569. doi:10.1158/1055-9965.EPI-10-0447

Minniti, G., Amelio, D., Amichetti, M., Salvati, M., Muni, R., Bozzao, A., . . . Enrici, R. M. (2010). Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol, 97(3), 377-381. doi:10.1016/j.radonc.2010.08.020

Mobed, K., Liu, R., Stewart, S., Wrensch, M., McCoy, L., Rice, T., . . . Chang, S. (2009). Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients. J Support Oncol, 7(6), W23-W31.

Mokhtech, M., Morris, C. G., Indelicato, D. J., Rutenberg, M. S., & Amdur, R. J. (2018). Patterns of Failure in Patients With Adult Medulloblastoma Presenting Without Extraneural Metastasis. Am J Clin Oncol, 41(10), 1015-1018. doi:10.1097/coc.0000000000000407

Moller, S., Grunnet, K., Hansen, S., Schultz, H., Holmberg, M., Sorensen, M., . . . Lassen, U. (2012). A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy. Acta Oncol, 51(6), 797-804. doi:10.3109/0284186X.2012.681063

Moller, S., Munck Af Rosenschold, P., Costa, J., Law, I., Poulsen, H. S., Engelholm, S. A., & Engelholm, S. (2017). Toxicity and efficacy of re-irradiation of high-grade glioma in a phase I dose- and volume escalation trial. Radiother Oncol, 125(2), 223-227. doi:10.1016/j.radonc.2017.09.039

Murray, M. J., Bailey, S., Heinemann, K., Mann, J., Gobel, U. K., Saran, F., . . . Nicholson, J. C. (2017). Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy. Int J Cancer, 141(3), 621-635. doi:10.1002/ijc.30755

Murray, M. J., Bartels, U., Nishikawa, R., Fangusaro, J., Matsutani, M., & Nicholson, J. C. (2015). Consensus on the management of intracranial germ-cell tumours. Lancet Oncol, 16(9), e470-e477. doi:10.1016/s1470-2045(15)00244-2

Napieralska, A., Braclik, I., Radwan, M., Mandera, M., & Blamek, S. (2019). Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma. Childs Nerv Syst, 35(2), 267-275. doi:10.1007/s00381-018-4010-8

Nationellt kvalitetsregister för hjärntumörer och centrala nervsystemet. Retrieved from https://www.cancercentrum.se/samverkan/cancerdiagnoser/hjarna-ryggmarg-och-hypofys/hjarna-och-ryggmarg/kvalitetsregister/

Navarria, P., Minniti, G., Clerici, E., Tomatis, S., Pinzi, V., Ciammella, P., . . . Scorsetti, M. (2019). Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO). J Neurooncol, 142(1), 59-67. doi:10.1007/s11060-018-03059-x

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Central Nervous System Cancers, Version 1, 2018 Retrieved from https://www.nccn.org/professionals/physician_gls/default.aspx

NCCN guidelines. Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/cns_blocks.pdf

Nelson, D. F., Diener-West, M., Horton, J., Chang, C. H., Schoenfeld, D., & Nelson, J. S. (1988). Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monogr(6), 279-284.

New, P. W., Eriks-Hoogland, I., Scivoletto, G., Reeves, R. K., Townson, A., Marshall, R., & Rathore, F. A. (2017). Important Clinical Rehabilitation Principles Unique to People with Non-traumatic Spinal Cord Dysfunction. Top Spinal Cord Inj Rehabil, 23(4), 299-312. doi:10.1310/sci2304-299

New, P. W., Marshall, R., Stubblefield, M. D., & Scivoletto, G. (2017). Rehabilitation of people with spinal cord damage due to tumor: literature review, international survey and practical recommendations for optimizing their rehabilitation. J Spinal Cord Med, 40(2), 213-221. doi:10.1080/10790268.2016.1173321

Nilsson, A., & Bjornsdottir, S. (2016). [Secondary osteoporosis is a often missed condition. Several large patient populations at risk]. Lakartidningen, 113.

Nixon, A. V., Narayanasamy, A., & Penny, V. (2013). An investigation into the spiritual needs of neuro-oncology patients from a nurse perspective. BMC Nurs, 12, 2. doi:10.1186/1472-6955-12-2

Nuno, M., Yu, J. J., Varshneya, K., Alexander, J., Mukherjee, D., Black, K. L., & Patil, C. G. (2016). Treatment and survival of supratentorial and posterior fossa ependymomas in adults. J Clin Neurosci, 28, 24-30. doi:10.1016/j.jocn.2015.11.014

Oh, M. C., Ivan, M. E., Sun, M. Z., Kaur, G., Safaee, M., Kim, J. M., . . . Parsa, A. T. (2013). Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas. Neuro Oncol, 15(2), 208-215. doi:10.1093/neuonc/nos286

Okada, H., Weller, M., Huang, R., Finocchiaro, G., Gilbert, M. R., Wick, W., . . . Reardon, D. A. (2015). Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol, 16(15), e534-542. doi:10.1016/S1470-2045(15)00088-1

Okorji, L. M., & Oberlin, D. T. (2016). Lower Urinary Tract Symptoms Secondary to Mass Lesion of the Brain: A Case Report and Review of the Literature. Urol Case Rep, 8, 7-8. doi:10.1016/j.eucr.2016.05.005

Olséni, L., & Wollmer, P. (2011). Sjukgymnastik vid nedsatt lungfunktion. Lund: Studentlitteratur.

Ostgathe, C., Gaertner, J., Kotterba, M., Klein, S., Lindena, G., Nauck, F., . . . Voltz, R. (2010). Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer, 18(9), 1157-1163. doi:10.1007/s00520-009-0735-y

Ostrom, Q. T., Adel Fahmideh, M., Cote, D. J., Muskens, I. S., Schraw, J. M., Scheurer, M. E., & Bondy, M. L. (2019). Risk factors for childhood and adult primary brain tumors. Neuro Oncol, 21(11), 1357-1375. doi:10.1093/neuonc/noz123

Ostrom, Q. T., Bauchet, L., Davis, F. G., Deltour, I., Fisher, J. L., Langer, C. E., . . . Barnholtz-Sloan, J. S. (2014). The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol, 16(7), 896-913. doi:10.1093/neuonc/nou087

Ostrom, Q. T., Gittleman, H., Xu, J., Kromer, C., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2016). CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. Neuro Oncol, 18(suppl_5), v1-v75. doi:10.1093/neuonc/now207

Ottenhausen, M., Ntoulias, G., Bodhinayake, I., Ruppert, F. H., Schreiber, S., Forschler, A., . . . Jodicke, A. (2019). Intradural spinal tumors in adults-update on management and outcome. Neurosurg Rev, 42(2), 371-388. doi:10.1007/s10143-018-0957-x

Oya, N., Shibamoto, Y., Nagata, Y., Negoro, Y., & Hiraoka, M. (2002). Postoperative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure. J Neurooncol, 56(1), 87-94.

Pace, A., Dirven, L., Koekkoek, J. A. F., Golla, H., Fleming, J., Ruda, R., . . . Taphoorn, M. J. B. (2017). European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol, 18(6), e330-e340. doi:10.1016/s1470-2045(17)30345-5

Pace, A., Parisi, C., Di Lelio, M., Zizzari, A., Petreri, G., Giovannelli, M., & Pompili, A. (2007). Home rehabilitation for brain tumor patients. J Exp Clin Cancer Res, 26(3), 297-300.

Pace, A., Vidiri, A., Galie, E., Carosi, M., Telera, S., Cianciulli, A. M., . . . Carapella, C. M. (2003). Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol, 14(12), 1722-1726.

Packer, R. J., Gajjar, A., Vezina, G., Rorke-Adams, L., Burger, P. C., Robertson, P. L., . . . Sposto, R. (2006). Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol, 24(25), 4202-4208. doi:10.1200/jco.2006.06.4980

Packer, R. J., Goldwein, J., Nicholson, H. S., Vezina, L. G., Allen, J. C., Ris, M. D., . . . Boyett, J. M. (1999). Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol, 17(7), 2127-2136. doi:10.1200/jco.1999.17.7.2127

Padovani, L., Sunyach, M. P., Perol, D., Mercier, C., Alapetite, C., Haie-Meder, C., . . . Carrie, C. (2007). Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys, 68(2), 433-440. doi:10.1016/j.ijrobp.2006.12.030

Pages, M., Pajtler, K. W., Puget, S., Castel, D., Boddaert, N., Tauziede-Espariat, A., . . . Andreiuolo, F. (2019). Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging. Brain Pathol, 29(3), 325-335. doi:10.1111/bpa.12664

Pajtler, K. W., Mack, S. C., Ramaswamy, V., Smith, C. A., Witt, H., Smith, A., . . . Taylor, M. D. (2017). The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathol, 133(1), 5-12. doi:10.1007/s00401-016-1643-0

Pajtler, K. W., Witt, H., Sill, M., Jones, D. T., Hovestadt, V., Kratochwil, F., . . . Pfister, S. M. (2015). Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell, 27(5), 728-743. doi:10.1016/j.ccell.2015.04.002

Pallud, J., Blonski, M., Mandonnet, E., Audureau, E., Fontaine, D., Sanai, N., . . . Capelle, L. (2013). Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas. Neuro Oncol, 15(5), 595-606. doi:10.1093/neuonc/nos331

Pallud, J., Taillandier, L., Capelle, L., Fontaine, D., Peyre, M., Ducray, F., . . . Mandonnet, E. (2012). Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates. Neurosurgery, 71(3), 729-739; discussion 739-740. doi:10.1227/NEU.0b013e31826213de

Palmer, G., Martling, A., Cedermark, B., & Holm, T. (2011). Preoperative tumour staging with multidisciplinary team assessment improves the outcome in locally advanced primary rectal cancer. Colorectal Dis, 13(12), 1361-1369. doi:10.1111/j.1463-1318.2010.02460.x

Panwalkar, P., Clark, J., Ramaswamy, V., Hawes, D., Yang, F., Dunham, C., . . . Venneti, S. (2017). Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome. Acta Neuropathol, 134(5), 705-714. doi:10.1007/s00401-017-1752-4

Patte, C., Frappaz, D., Raquin, M. A., Bouffet, E., Kalifa, C., & Baranzelli, M. C. (2002). Treatment of Primary Intracranial Germ Cell Tumours with Carboplatin-based Chemotherapy and Focal Irradiation, London.

Peeters, S., Pages, M., Gauchotte, G., Miquel, C., Cartalat-Carel, S., Guillamo, J. S., . . . the Association des Neuro-Oncologues d'Expression, F. (2017). Interactions between glioma and pregnancy: insight from a 52-case multicenter series. J Neurosurg, 1-11. doi:10.3171/2016.10.JNS16710

Perry, J. R., Laperriere, N., O'Callaghan, C. J., Brandes, A. A., Menten, J., Phillips, C., . . . Trial, I. (2017). Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma. N Engl J Med, 376(11), 1027-1037. doi:10.1056/NEJMoa1611977

Perry, J. R., Rizek, P., Cashman, R., Morrison, M., & Morrison, T. (2008). Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach. Cancer, 113(8), 2152-2157. doi:10.1002/cncr.23813

Persson, O., Fletcher-Sandersjoo, A., Burstrom, G., Edstrom, E., & Elmi-Terander, A. (2019). Surgical Treatment of Intra- and Juxtamedullary Spinal Cord Tumors: A Population Based Observational Cohort Study. Front Neurol, 10, 814. doi:10.3389/fneur.2019.00814

Peterson, C. (2005). [Natural remedies--self care at your own risk! Danger of unknown adverse effects and interactions with "common" medications]. Lakartidningen, 102(44), 3200-3201.

Petruzzi, A., Finocchiaro, C. Y., Lamperti, E., & Salmaggi, A. (2013). Living with a brain tumor : reaction profiles in patients and their caregivers. Support Care Cancer, 21(4), 1105-1111. doi:10.1007/s00520-012-1632-3

Peyre, M., Cartalat-Carel, S., Meyronet, D., Ricard, D., Jouvet, A., Pallud, J., . . . Ducray, F. (2010). Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas. Neuro Oncol, 12(10), 1078-1082. doi:10.1093/neuonc/noq055

Phillips, C., Guiney, M., Smith, J., Hughes, P., Narayan, K., & Quong, G. (2003). A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother Oncol, 68(1), 23-26.

Phillips, K. A., Fadul, C. E., & Schiff, D. (2018). Neurologic and Medical Management of Brain Tumors. Neurol Clin, 36(3), 449-466. doi:10.1016/j.ncl.2018.04.004

Pichlmeier, U., Bink, A., Schackert, G., Stummer, W., & Group, A. L. A. G. S. (2008). Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol, 10(6), 1025-1034. doi:10.1215/15228517-2008-052

Pietsch, T., & Haberler, C. (2016). Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline. Clin Neuropathol, 35(6), 344-352. doi:10.5414/np300999

Pignatti, F., van den Bent, M., Curran, D., Debruyne, C., Sylvester, R., Therasse, P., . . . Treatment of Cancer Radiotherapy Cooperative, G. (2002). Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol, 20(8), 2076-2084.

Piil, K., Juhler, M., Jakobsen, J., & Jarden, M. (2016). Controlled rehabilitative and supportive care intervention trials in patients with high-grade gliomas and their caregivers: a systematic review. BMJ Support Palliat Care, 6(1), 27-34. doi:10.1136/bmjspcare-2013-000593

Pirotte, B., Goldman, S., Massager, N., David, P., Wikler, D., Vandesteene, A., . . . Levivier, M. (2004). Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med, 45(8), 1293-1298.

Poynter, J. N., Fonstad, R., Tolar, J., Spector, L. G., & Ross, J. A. (2014). Incidence of intracranial germ cell tumors by race in the United States, 1992-2010. J Neurooncol, 120(2), 381-388. doi:10.1007/s11060-014-1562-7

Prabhu, S., Chabardes, S., Sherdil, A., Devergnas, A., Michallat, S., Bhattacharjee, M., . . . Piallat, B. (2015). Effect of subthalamic nucleus stimulation on penicillin induced focal motor seizures in primate. Brain Stimul, 8(2), 177-184. doi:10.1016/j.brs.2014.10.017

Praktisk vägledning vid trakeostomi och hemventilatorvård. Danderyd: Nationellt Respirationscentrum. Retrieved from https://www.ds.se/patient-och-narstaende/mottagningar-och-avdelningar/nationellt-respirationscentrum/

Privitera, G., Acquaviva, G., Ettorre, G. C., & Spatola, C. (2009). Antiangiogenic therapy in the treatment of recurrent medulloblastoma in the adult: case report and review of the literature. J Oncol, 2009, 247873. doi:10.1155/2009/247873

Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors (SIOPCNSGCTII). (June 4, 2015 ). Retrieved from https://clinicaltrials.gov/ct2/show/NCT01424839

Qi, Z. Y., Shao, C., Zhang, X., Hui, G. Z., & Wang, Z. (2013). Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies. PLoS One, 8(7), e68695. doi:10.1371/journal.pone.0068695

Quinn, J. A., Reardon, D. A., Friedman, A. H., Rich, J. N., Sampson, J. H., Provenzale, J. M., . . . Friedman, H. S. (2003). Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol, 21(4), 646-651.

Ramaswamy, V., Remke, M., Bouffet, E., Bailey, S., Clifford, S. C., Doz, F., . . . Pomeroy, S. L. (2016). Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol, 131(6), 821-831. doi:10.1007/s00401-016-1569-6

Ray, J. G., Bharatha, A., & Montanera, W. J. (2016). Magnetic Resonance Imaging Exposure During Pregnancy-Reply. JAMA, 316(21), 2275-2276. doi:10.1001/jama.2016.17302

Rekand, T., Hagen, E. M., & Gronning, M. (2012). Spasticity following spinal cord injury. Tidsskr Nor Laegeforen, 132(8), 970-973. doi:10.4045/tidsskr.10.0872

Remke, M., Hielscher, T., Northcott, P. A., Witt, H., Ryzhova, M., Wittmann, A., . . . Korshunov, A. (2011). Adult medulloblastoma comprises three major molecular variants. J Clin Oncol, 29(19), 2717-2723. doi:10.1200/jco.2011.34.9373

The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2. (2017). J Neurosurg Spine, 26(4), 474-482. doi:10.3171/2016.8.Spine16589

Reuss, D. E., Kratz, A., Sahm, F., Capper, D., Schrimpf, D., Koelsche, C., . . . von Deimling, A. (2015). Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol, 130(3), 407-417. doi:10.1007/s00401-015-1454-8

Reuss, D. E., Sahm, F., Schrimpf, D., Wiestler, B., Capper, D., Koelsche, C., . . . von Deimling, A. (2015). ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol, 129(1), 133-146. doi:10.1007/s00401-014-1370-3

Ribom, D., Eriksson, A., Hartman, M., Engler, H., Nilsson, A., Langstrom, B., . . . Smits, A. (2001). Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Cancer, 92(6), 1541-1549.

Ricard, D., Kaloshi, G., Amiel-Benouaich, A., Lejeune, J., Marie, Y., Mandonnet, E., . . . Delattre, J. Y. (2007). Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol, 61(5), 484-490. doi:10.1002/ana.21125

Roa, W., Brasher, P. M., Bauman, G., Anthes, M., Bruera, E., Chan, A., . . . Forsyth, P. (2004). Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol, 22(9), 1583-1588. doi:10.1200/JCO.2004.06.082

Roa, W., Kepka, L., Kumar, N., Sinaika, V., Matiello, J., Lomidze, D., . . . Fidarova, E. (2015). International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme. J Clin Oncol, 33(35), 4145-4150. doi:10.1200/JCO.2015.62.6606

Robertson, M. E., McSherry, F., Herndon, J. E., & Peters, K. B. (2016). Insomnia and its associations in patients with recurrent glial neoplasms. Springerplus, 5(1), 823. doi:10.1186/s40064-016-2578-6

Robin, A. M., Walbert, T., Mikkelsen, T., Kalkanis, S. N., Rock, J., Lee, I., & Rosenblum, M. L. (2014). Through the patient's eyes: the value of a comprehensive brain tumor center. J Neurooncol, 119(3), 465-472. doi:10.1007/s11060-014-1494-2

Roelz, R., Strohmaier, D., Jabbarli, R., Kraeutle, R., Egger, K., Coenen, V. A., . . . Reinacher, P. C. (2016). Residual Tumor Volume as Best Outcome Predictor in Low Grade Glioma - A Nine-Years Near-Randomized Survey of Surgery vs. Biopsy. Sci Rep, 6, 32286. doi:10.1038/srep32286

Rogers, L., Pueschel, J., Spetzler, R., Shapiro, W., Coons, S., Thomas, T., & Speiser, B. (2005). Is gross-total resection sufficient treatment for posterior fossa ependymomas? J Neurosurg, 102(4), 629-636. doi:10.3171/jns.2005.102.4.0629

Rogers, S. J., Mosleh-Shirazi, M. A., & Saran, F. H. (2005). Radiotherapy of localised intracranial germinoma: time to sever historical ties? Lancet Oncol, 6(7), 509-519. doi:10.1016/s1470-2045(05)70245-x

Ronning, P. A., Helseth, E., Meling, T. R., & Johannesen, T. B. (2016). The effect of pregnancy on survival in a low-grade glioma cohort. J Neurosurg, 125(2), 393-400. doi:10.3171/2015.6.JNS15985

Roosli, M., Lagorio, S., Schoemaker, M. J., Schuz, J., & Feychting, M. (2019). Brain and Salivary Gland Tumors and Mobile Phone Use: Evaluating the Evidence from Various Epidemiological Study Designs. Annu Rev Public Health, 40, 221-238. doi:10.1146/annurev-publhealth-040218-044037

Roth, P., Happold, C., & Weller, M. (2015). Corticosteroid use in neuro-oncology: an update. Neurooncol Pract, 2(1), 6-12. doi:10.1093/nop/npu029

Ruda, R., Bello, L., Duffau, H., & Soffietti, R. (2012). Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol, 14 Suppl 4, iv55-64. doi:10.1093/neuonc/nos199

Ruda, R., Bosa, C., Magistrello, M., Franchino, F., Pellerino, A., Fiano, V., . . . Soffietti, R. (2016). Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study. Neuro Oncol, 18(2), 261-268. doi:10.1093/neuonc/nov167

Ruda, R., Magliola, U., Bertero, L., Trevisan, E., Bosa, C., Mantovani, C., . . . Soffietti, R. (2013). Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro Oncol, 15(12), 1739-1749. doi:10.1093/neuonc/not109

Ruda, R., Reifenberger, G., Frappaz, D., Pfister, S. M., Laprie, A., Santarius, T., . . . Moyal, E. C. (2018). EANO guidelines for the diagnosis and treatment of ependymal tumors. Neuro Oncol, 20(4), 445-456. doi:10.1093/neuonc/nox166

Ruppert, L. M. (2017). Malignant Spinal Cord Compression: Adapting Conventional Rehabilitation Approaches. Phys Med Rehabil Clin N Am, 28(1), 101-114. doi:10.1016/j.pmr.2016.08.007

Ryggmärgsskada. Retrieved from https://ryggmärgsskada.se/ryggmargsskada/

Ryu, S., Buatti, J. M., Morris, A., Kalkanis, S. N., Ryken, T. C., Olson, J. J., & Committee, A. C. J. G. (2014). The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neurooncol, 118(3), 489-499. doi:10.1007/s11060-013-1337-6

Sadetzki, S., Bruchim, R., Oberman, B., Armstrong, G. N., Lau, C. C., Claus, E. B., . . . Gliogene, C. (2013). Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. Eur J Cancer, 49(6), 1335-1345. doi:10.1016/j.ejca.2012.11.009

Salander, P. (2012). Cancer and "playing" with reality: clinical guidance with the help of the intermediate area and disavowal. Acta Oncol, 51(4), 541-560. doi:10.3109/0284186X.2011.639389

Salander, P., Bergenheim, A. T., & Henriksson, R. (2000). How was life after treatment of a malignant brain tumour? Soc Sci Med, 51(4), 589-598. doi:10.1016/s0277-9536(00)00002-2

Salander, P., Bergenheim, T., & Henriksson, R. (1996). The creation of protection and hope in patients with malignant brain tumours. Soc Sci Med, 42(7), 985-996.

Salander, P., Bergknut, M., & Henriksson, R. (2014). The creation of hope in patients with lung cancer. Acta Oncol, 53(9), 1205-1211. doi:10.3109/0284186X.2014.921725

Sandberg-Wollheim, M., Malmstrom, P., Stromblad, L. G., Anderson, H., Borgstrom, S., Brun, A., . . . Salford, L. G. (1991). A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer, 68(1), 22-29.

Sandstrom, M., Laudius, M., Lindqvist, T., Asklund, T., & Johansson, M. (2017). A Retrospective Evaluation of Bevacizumab Treatment in Patients with Progressive Malignant Glioma in Northern Sweden. Anticancer Res, 37(4), 1869-1874. doi:10.21873/anticanres.11524

Schild, S. E., Nisi, K., Scheithauer, B. W., Wong, W. W., Lyons, M. K., Schomberg, P. J., & Shaw, E. G. (1998). The results of radiotherapy for ependymomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys, 42(5), 953-958. doi:10.1016/s0360-3016(98)00350-2

Schild, S. E., Wong, W., & Nisi, K. (2002). In regard to the radiotherapy of myxopapillary ependymomas. Int J Radiat Oncol Biol Phys, 53(3), 787. doi:10.1016/s0360-3016(02)02776-1

Schmidt, F., Fischer, J., Herrlinger, U., Dietz, K., Dichgans, J., & Weller, M. (2006). PCV chemotherapy for recurrent glioblastoma. Neurology, 66(4), 587-589. doi:10.1212/01.wnl.0000197792.73656.c2

Schreck, K. C., Ranjan, S., Skorupan, N., Bettegowda, C., Eberhart, C. G., Ames, H. M., & Holdhoff, M. (2019). Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. J Neurooncol, 143(1), 87-93. doi:10.1007/s11060-019-03134-x

Schroter, S., Halatsch, M. E., Behnke-Mursch, J., & Mursch, K. (2009). Self-help activities of brain tumour patients and their relatives. Cent Eur Neurosurg, 70(1), 21-26. doi:10.1055/s-0028-1087215

Schubart, J. R., Kinzie, M. B., & Farace, E. (2008). Caring for the brain tumor patient: family caregiver burden and unmet needs. Neuro Oncol, 10(1), 61-72. doi:10.1215/15228517-2007-040

Scoccianti, S., Detti, B., Gadda, D., Greto, D., Furfaro, I., Meacci, F., . . . Livi, L. (2015). Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist's guide for delineation in everyday practice. Radiother Oncol, 114(2), 230-238. doi:10.1016/j.radonc.2015.01.016

Sepulveda-Sanchez, J. M., Conde-Moreno, A., Baron, M., Pardo, J., Reynes, G., & Belenguer, A. (2017). Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study. Oncol Lett, 13(6), 4093-4100. doi:10.3892/ol.2017.5988

Shapiro, W. R., Green, S. B., Burger, P. C., Mahaley, M. S., Jr., Selker, R. G., VanGilder, J. C., . . . et al. (1989). Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg, 71(1), 1-9. doi:10.3171/jns.1989.71.1.0001

Shapiro, W. R., & Young, D. F. (1976). Treatment of malignant glioma. A controlled study of chemotherapy and irradiation. Arch Neurol, 33(7), 494-450.

Shaw, E., Arusell, R., Scheithauer, B., O'Fallon, J., O'Neill, B., Dinapoli, R., . . . Abrams, R. (2002). Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol, 20(9), 2267-2276.

Shaw, E. G., Evans, R. G., Scheithauer, B. W., Ilstrup, D. M., & Earle, J. D. (1986). Radiotherapeutic management of adult intraspinal ependymomas. Int J Radiat Oncol Biol Phys, 12(3), 323-327. doi:10.1016/0360-3016(86)90345-7

Shenouda, G., Souhami, L., Petrecca, K., Owen, S., Panet-Raymond, V., Guiot, M. C., . . . Abdulkarim, B. (2017). A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma. Int J Radiat Oncol Biol Phys, 97(3), 487-494. doi:10.1016/j.ijrobp.2016.11.006

Shibamoto, Y., Sasai, K., Oya, N., & Hiraoka, M. (2001). Intracranial germinoma: radiation therapy with tumor volume-based dose selection. Radiology, 218(2), 452-456. doi:10.1148/radiology.218.2.r01ja08452

Shields, L. B., & Choucair, A. K. (2014). Management of low-grade gliomas: a review of patient-perceived quality of life and neurocognitive outcome. World Neurosurg, 82(1-2), e299-309. doi:10.1016/j.wneu.2014.02.033

Siegel, C., & Armstrong, T. S. (2018). Nursing Guide to Management of Major Symptoms in Patients with Malignant Glioma. Semin Oncol Nurs, 34(5), 513-527. doi:10.1016/j.soncn.2018.10.014

Silvera, S. A., Miller, A. B., & Rohan, T. E. (2006). Hormonal and reproductive factors and risk of glioma: a prospective cohort study. Int J Cancer, 118(5), 1321-1324. doi:10.1002/ijc.21467

Silverman, S. L., & Lane, N. E. (2009). Glucocorticoid-induced osteoporosis. Curr Osteoporos Rep, 7(1), 23-26.

Sittdynor och underlägg för tryckksårsprevention (043303). Retrieved from https://www.vardgivarguiden.se/behandlingsstod/hjalpmedelsguiden/behovstrappor/vard-och-behandling/fysiska-funktioner/sar-cirkulation/antidecubitus/sittdynor-trycksarsprevention/

Sizoo, E. M., Braam, L., Postma, T. J., Pasman, H. R., Heimans, J. J., Klein, M., . . . Taphoorn, M. J. (2010). Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro Oncol, 12(11), 1162-1166. doi:10.1093/neuonc/nop045

Sminia, P., & Mayer, R. (2012). External beam radiotherapy of recurrent glioma: radiation tolerance of the human brain. Cancers (Basel), 4(2), 379-399. doi:10.3390/cancers4020379

Smith, J. S., Chang, E. F., Lamborn, K. R., Chang, S. M., Prados, M. D., Cha, S., . . . Berger, M. S. (2008). Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol, 26(8), 1338-1345. doi:10.1200/JCO.2007.13.9337

Smith, K. C. (2010). The management of seizures in brain tumor patients. J Neurosci Nurs, 42(1), 28-37; quiz 38-29.

Smoll, N. R., & Drummond, K. J. (2012). The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children. J Clin Neurosci, 19(11), 1541-1544. doi:10.1016/j.jocn.2012.04.009

Smärta, neuropatisk. Retrieved from https://www.internetmedicin.se/page.aspx?id=1607

Sneed, P. K., Albright, N. W., Wara, W. M., Prados, M. D., & Wilson, C. B. (1995). Fetal dose estimates for radiotherapy of brain tumors during pregnancy. Int J Radiat Oncol Biol Phys, 32(3), 823-830. doi:10.1016/0360-3016(94)00456-U

Soffietti, R., Baumert, B. G., Bello, L., von Deimling, A., Duffau, H., Frenay, M., . . . European Federation of Neurological, S. (2010). Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol, 17(9), 1124-1133. doi:10.1111/j.1468-1331.2010.03151.x

Soffietti, R., Ruda, R., Bradac, G. B., & Schiffer, D. (1998). PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery, 43(5), 1066-1073.

Sohlberg, M. M., & Turkstra, L. (2011). Optimizing cognitive rehabilitation : effective instructional methods. New York: Guilford Press.

Speck, R. M., Courneya, K. S., Masse, L. C., Duval, S., & Schmitz, K. H. (2010). An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv, 4(2), 87-100. doi:10.1007/s11764-009-0110-5

Spetz, A., Henriksson, R., & Salander, P. (2008). A specialist nurse as a resource for family members to patients with brain tumors: an action research study. Cancer Nurs, 31(4), E18-26. doi:10.1097/01.NCC.0000305741.18711.8f

Standardiserat vårdförlopp primära maligna hjärntumörer. Retrieved from https://www.cancercentrum.se/samverkan/cancerdiagnoser/hjarna-ryggmarg-och-hypofys/hjarna-och-ryggmarg/vardforlopp-hjarna/

Statistik om cancer. (2019-08-23 ). Retrieved from https://www.socialstyrelsen.se/statistik-och-data/statistik/statistikamnen/cancer/

Stege, E. M., Kros, J. M., de Bruin, H. G., Enting, R. H., van Heuvel, I., Looijenga, L. H., . . . van den Bent, M. J. (2005). Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine. Cancer, 103(4), 802-809. doi:10.1002/cncr.20828

Stewart, L. A. (2002). Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet, 359(9311), 1011-1018.

Stummer, W., Novotny, A., Stepp, H., Goetz, C., Bise, K., & Reulen, H. J. (2000). Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg, 93(6), 1003-1013. doi:10.3171/jns.2000.93.6.1003

Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., . . . National Cancer Institute of Canada Clinical Trials, G. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol, 10(5), 459-466. doi:10.1016/S1470-2045(09)70025-7

Stupp, R., Taillibert, S., Kanner, A., Read, W., Steinberg, D. M., Lhermitte, B., . . . Ram, Z. (2017). Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA, 318(23), 2306-2316. doi:10.1001/jama.2017.18718

Stupp, R., Taillibert, S., Kanner, A. A., Kesari, S., Steinberg, D. M., Toms, S. A., . . . Ram, Z. (2015). Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. JAMA, 314(23), 2535-2543. doi:10.1001/jama.2015.16669

Stupp, R., Wong, E. T., Kanner, A. A., Steinberg, D., Engelhard, H., Heidecke, V., . . . Gutin, P. H. (2012). NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer, 48(14), 2192-2202. doi:10.1016/j.ejca.2012.04.011

Suggested protocol Philips Respironics CoughAssist E70. . (2019-03-19). Retrieved from https://www.philips.se/healthcare/product/HC1098159/coughassist-e70-mechanical-insufflatorexsufflator/dokumentation

Taal, W., Oosterkamp, H. M., Walenkamp, A. M., Dubbink, H. J., Beerepoot, L. V., Hanse, M. C., . . . van den Bent, M. J. (2014). Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial. Lancet Oncol, 15(9), 943-953. doi:10.1016/S1470-2045(14)70314-6

Taylor, M. D., Northcott, P. A., Korshunov, A., Remke, M., Cho, Y. J., Clifford, S. C., . . . Pfister, S. M. (2012). Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol, 123(4), 465-472. doi:10.1007/s00401-011-0922-z

Taylor, R. E. (2004). Review of radiotherapy dose and volume for intracranial ependymoma. Pediatr Blood Cancer, 42(5), 457-460. doi:10.1002/pbc.10470

Tensaouti, F., Ducassou, A., Chaltiel, L., Bolle, S., Muracciole, X., Coche-Dequeant, B., . . . Laprie, A. (2017). Patterns of failure after radiotherapy for pediatric patients with intracranial ependymoma. Radiotherapy and Oncology, 122(3), 362-367. doi:https://doi.org/10.1016/j.radonc.2016.12.025

Terakawa, Y., Tsuyuguchi, N., Iwai, Y., Yamanaka, K., Higashiyama, S., Takami, T., & Ohata, K. (2008). Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med, 49(5), 694-699. doi:10.2967/jnumed.107.048082

Thakkar, J. P., Chew, L., & Villano, J. L. (2013). Primary CNS germ cell tumors: current epidemiology and update on treatment. Med Oncol, 30(2), 496. doi:10.1007/s12032-013-0496-9

Theeler, B. J., Ellezam, B., Sadighi, Z. S., Mehta, V., Tran, M. D., Adesina, A. M., . . . Puduvalli, V. K. (2014). Adult pilocytic astrocytomas: clinical features and molecular analysis. Neuro Oncol, 16(6), 841-847. doi:10.1093/neuonc/not246

Thorp, N., & Gandola, L. (2019). Management of Ependymoma in Children, Adolescents and Young Adults. Clin Oncol (R Coll Radiol), 31(3), 162-170. doi:10.1016/j.clon.2018.12.001

Tinchon, A., Oberndorfer, S., Marosi, C., Ruda, R., Sax, C., Calabek, B., & Grisold, W. (2012). Malignant spinal cord compression in cerebral glioblastoma multiforme: a multicenter case series and review of the literature. J Neurooncol, 110(2), 221-226. doi:10.1007/s11060-012-0955-8

Torelli, F., Terragni, E., Blanco, S., Di Bella, N., Grasso, M., & Bonaiuti, D. (2015). Lower urinary tract symptoms associated with neurological conditions: Observations on a clinical sample of outpatients neurorehabilitation service. Arch Ital Urol Androl, 87(2), 154-157. doi:10.4081/aiua.2015.2.154

Tosoni, A., Franceschi, E., Ermani, M., Bertorelle, R., Bonaldi, L., Blatt, V., & Brandes, A. A. (2008). Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas. J Neurooncol, 89(2), 179-185. doi:10.1007/s11060-008-9600-y

Triebels, V. H., Taphoorn, M. J., Brandes, A. A., Menten, J., Frenay, M., Tosoni, A., . . . van den Bent, M. J. (2004). Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas. Neurology, 63(5), 904-906.

Trifiletti, D. M., Peach, M. S., Xu, Z., Kersh, R., Showalter, T. N., & Sheehan, J. P. (2017). Evaluation of outcomes after stereotactic radiosurgery for pilocytic astrocytoma. J Neurooncol, 134(2), 297-302. doi:10.1007/s11060-017-2521-x

Tryggare bostad för personer med epilepsi. (1997). Retrieved from http://epilepsi.se/pdf/Tryggare-bostad-foer-personer.pdf

Walker, M. D., Alexander, E., Jr., Hunt, W. E., MacCarty, C. S., Mahaley, M. S., Jr., Mealey, J., Jr., . . . Strike, T. A. (1978). Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg, 49(3), 333-343. doi:10.3171/jns.1978.49.3.0333

Wallner, K. E., Galicich, J. H., Krol, G., Arbit, E., & Malkin, M. G. (1989). Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys, 16(6), 1405-1409.

van Breemen, M. S., Wilms, E. B., & Vecht, C. J. (2007). Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol, 6(5), 421-430. doi:10.1016/S1474-4422(07)70103-5

van den Bent, M. J., Afra, D., de Witte, O., Ben Hassel, M., Schraub, S., Hoang-Xuan, K., . . . the, U. K. M. R. C. (2005). Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet, 366(9490), 985-990. doi:10.1016/S0140-6736(05)67070-5

van den Bent, M. J., Baumert, B., Erridge, S. C., Vogelbaum, M. A., Nowak, A. K., Sanson, M., . . . Kros, J. M. (2017). Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Lancet. doi:10.1016/S0140-6736(17)31442-3

van den Bent, M. J., Brandes, A. A., Taphoorn, M. J., Kros, J. M., Kouwenhoven, M. C., Delattre, J. Y., . . . Hoang-Xuan, K. (2013). Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol, 31(3), 344-350. doi:10.1200/JCO.2012.43.2229

van den Bent, M. J., Chinot, O., Boogerd, W., Bravo Marques, J., Taphoorn, M. J., Kros, J. M., . . . Baron, B. (2003). Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. Ann Oncol, 14(4), 599-602.

van den Bent, M. J., Dubbink, H. J., Sanson, M., van der Lee-Haarloo, C. R., Hegi, M., Jeuken, J. W., . . . Kros, J. M. (2009). MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951. J Clin Oncol, 27(35), 5881-5886. doi:10.1200/jco.2009.24.1034

van den Bent, M. J., Taphoorn, M. J., Brandes, A. A., Menten, J., Stupp, R., Frenay, M., . . . Treatment of Cancer Brain Tumor, G. (2003). Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol, 21(13), 2525-2528. doi:10.1200/JCO.2003.12.015

van den Bent, M. J., Wefel, J. S., Schiff, D., Taphoorn, M. J., Jaeckle, K., Junck, L., . . . Jacobs, A. H. (2011). Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol, 12(6), 583-593. doi:10.1016/S1470-2045(11)70057-2

Wang, L., Yamaguchi, S., Burstein, M. D., Terashima, K., Chang, K., Ng, H. K., . . . Lau, C. C. (2014). Novel somatic and germline mutations in intracranial germ cell tumours. Nature, 511(7508), 241-245. doi:10.1038/nature13296

Wang, S. S., Hartge, P., Yeager, M., Carreon, T., Ruder, A. M., Linet, M., . . . Rajaraman, P. (2011). Joint associations between genetic variants and reproductive factors in glioma risk among women. Am J Epidemiol, 174(8), 901-908. doi:10.1093/aje/kwr184

Vargo, M., Henriksson, R., & Salander, P. (2016). Rehabilitation of patients with glioma. Handb Clin Neurol, 134, 287-304. doi:10.1016/b978-0-12-802997-8.00017-7

Vecht, C. J., Kerkhof, M., & Duran-Pena, A. (2014). Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist, 19(7), 751-759. doi:10.1634/theoncologist.2014-0060

Weller, M., Gorlia, T., Cairncross, J. G., van den Bent, M. J., Mason, W., Belanger, K., . . . Stupp, R. (2011). Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology, 77(12), 1156-1164. doi:10.1212/WNL.0b013e31822f02e1

Weller, M., Tabatabai, G., Kastner, B., Felsberg, J., Steinbach, J. P., Wick, A., . . . Group, D. S. (2015). MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial. Clin Cancer Res, 21(9), 2057-2064. doi:10.1158/1078-0432.CCR-14-2737

Weller, M., van den Bent, M., Tonn, J. C., Stupp, R., Preusser, M., Cohen-Jonathan-Moyal, E., . . . European Association for Neuro-Oncology Task Force on, G. (2017). European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncol, 18(6), e315-e329. doi:10.1016/S1470-2045(17)30194-8

Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., . . . Chang, S. M. (2010). Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol, 28(11), 1963-1972. doi:10.1200/JCO.2009.26.3541

White, J. B., Miller, G. M., Layton, K. F., & Krauss, W. E. (2007). Nonenhancing tumors of the spinal cord. J Neurosurg Spine, 7(4), 403-407. doi:10.3171/SPI-07/09/10/403

White, M. J., Thornton, J. S., Hawkes, D. J., Hill, D. L., Kitchen, N., Mancini, L., . . . Keevil, S. F. (2015). Design, operation, and safety of single-room interventional MRI suites: practical experience from two centers. J Magn Reson Imaging, 41(1), 34-43. doi:10.1002/jmri.24577

Wick, W., Gorlia, T., Bendszus, M., Taphoorn, M., Sahm, F., Harting, I., . . . van den Bent, M. J. (2017). Lomustine and Bevacizumab in Progressive Glioblastoma. N Engl J Med, 377(20), 1954-1963. doi:10.1056/NEJMoa1707358

Wick, W., Meisner, C., Hentschel, B., Platten, M., Schilling, A., Wiestler, B., . . . Weller, M. (2013). Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Neurology, 81(17), 1515-1522. doi:10.1212/WNL.0b013e3182a95680

Wick, W., Platten, M., Meisner, C., Felsberg, J., Tabatabai, G., Simon, M., . . . Society, N. O. A. S. G. o. N.-o. W. G. o. G. C. (2012). Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol, 13(7), 707-715. doi:10.1016/S1470-2045(12)70164-X

Wick, W., Puduvalli, V. K., Chamberlain, M. C., van den Bent, M. J., Carpentier, A. F., Cher, L. M., . . . Fine, H. A. (2010). Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma. J Clin Oncol, 28(7), 1168-1174. doi:10.1200/JCO.2009.23.2595

Wick, W., Roth, P., Hartmann, C., Hau, P., Nakamura, M., Stockhammer, F., . . . Neurooncology Working Group of the German Cancer, S. (2016). Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. Neuro Oncol, 18(11), 1529-1537. doi:10.1093/neuonc/now133

Wigertz, A., Lonn, S., Hall, P., Auvinen, A., Christensen, H. C., Johansen, C., . . . Feychting, M. (2008). Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev, 17(10), 2663-2670. doi:10.1158/1055-9965.EPI-08-0406

Villanueva, V., Saiz-Diaz, R., Toledo, M., Piera, A., Mauri, J. A., Rodriguez-Uranga, J. J., . . . Gago, A. (2016). NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy. Epilepsy Behav, 65, 25-32. doi:10.1016/j.yebeh.2016.09.033

Witt, H., Gramatzki, D., Hentschel, B., Pajtler, K. W., Felsberg, J., Schackert, G., . . . Weller, M. (2018). DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment. Neuro Oncol, 20(12), 1616-1624. doi:10.1093/neuonc/noy118

Vogelbaum, M. A., Jost, S., Aghi, M. K., Heimberger, A. B., Sampson, J. H., Wen, P. Y., . . . Chang, S. M. (2012). Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery, 70(1), 234-243; discussion 243-234. doi:10.1227/NEU.0b013e318223f5a7

von Thiele Schwarz, U. (2016). Co-care: Producing better health outcome through interactions between patients, care providers and information and communication technology. Health Services Management Research, 29(1-2), 10-15. doi:10.1177/0951484816637746

Woodhouse, K. D., Tremont, K., Vachani, A., Schapira, M. M., Vapiwala, N., Simone, C. B., 2nd, & Berman, A. T. (2017). A Review of Shared Decision-Making and Patient Decision Aids in Radiation Oncology. J Cancer Educ, 32(2), 238-245. doi:10.1007/s13187-017-1169-8

World Health Organization. Self-care in the context of primary health care. Report of the Regional Consultation, Bangkok, Thailand, 7–9 January 2009.

Vredenburgh, J. J., Desjardins, A., Herndon, J. E., 2nd, Marcello, J., Reardon, D. A., Quinn, J. A., . . . Friedman, H. S. (2007). Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol, 25(30), 4722-4729. doi:10.1200/JCO.2007.12.2440

Wright, F. C., De Vito, C., Langer, B., Hunter, A., & Expert Panel on Multidisciplinary Cancer Conference, S. (2007). Multidisciplinary cancer conferences: a systematic review and development of practice standards. Eur J Cancer, 43(6), 1002-1010. doi:10.1016/j.ejca.2007.01.025

Vuorinen, V., Hinkka, S., Farkkila, M., & Jaaskelainen, J. (2003). Debulking or biopsy of malignant glioma in elderly people - a randomised study. Acta Neurochir (Wien), 145(1), 5-10. doi:10.1007/s00701-002-1030-6

Yung, W. K., Prados, M. D., Yaya-Tur, R., Rosenfeld, S. S., Brada, M., Friedman, H. S., . . . Levin, V. A. (1999). Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol, 17(9), 2762-2771. doi:10.1200/JCO.1999.17.9.2762

Yust-Katz, S., de Groot, J. F., Liu, D., Wu, J., Yuan, Y., Anderson, M. D., . . . Armstrong, T. S. (2014). Pregnancy and glial brain tumors. Neuro Oncol, 16(9), 1289-1294. doi:10.1093/neuonc/nou019

Zong, H., Xu, H., Geng, Z., Ma, C., Ming, X., Shang, M., . . . Cao, L. (2014). Reproductive factors in relation to risk of brain tumors in women: an updated meta-analysis of 27 independent studies. Tumour Biol, 35(11), 11579-11586. doi:10.1007/s13277-014-2448-1

Zwicker, J. I., Karp Leaf, R., & Carrier, M. (2016). A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. J Thromb Haemost, 14(9), 1736-1740. doi:10.1111/jth.13387

Zwinkels, H., Dorr, J., Kloet, F., Taphoorn, M. J., & Vecht, C. J. (2013). Pregnancy in women with gliomas: a case-series and review of the literature. J Neurooncol, 115(2), 293-301. doi:10.1007/s11060-013-1229-9

Nästa kapitel
23 Förslag på fördjupning